Dermatographic urticaria

L12_URTICA_DERTMATOG

dermatographia: Familial dermographism is a condition also known as skin writing. When people who have dermatographia lightly scratch their skin, the scratches redden into a raised wheal similar to hives. Signs and symptoms of dermatographia include raised red lines, swelling, inflammation, hive-like welts and itching. Symptoms usually disappear within 30 minutes. The exact cause of this condition is unknown. Treatment mayinvovle use of antihistamines if symptoms do not go away on their own.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L50.3 Hospital discharge: ICD-9 — 7083 Cause of death: ICD-10 — L50.3 Cause of death: ICD-9 — 7083 2 out of 7 registries used, show all original rules.	2838
4. Check minimum number of events None	2838
5. Include endpoints None	2838
6. Filter based on genotype QC (FinnGen only)	2725

Control definitions (FinnGen only)

Control exclude: L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L50
Name in latin: Urticaria derm[at]ographica

NAME	L12_URTICA_DERTMATOG
CONTROL_EXCLUDE	L12_URTICARIAERYTHEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L503
HD_ICD_9	7083
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L503
COD_ICD_9	7083
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dermatographic urticaria based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	15685	11264	4351
Only index persons	15227	11048	4179
Unadjusted period prevalence (%)
Whole population	0.27	0.32	0.12
Only index persons	0.34	0.41	0.16
Median age at first event (years)
Whole population	41.50	41.98	40.28
Only index persons	41.59	42.07	40.32

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2725	2162	563
Unadjusted period prevalence (%)	0.66	0.77	0.26
Median age at first event (years)	46.13	44.63	51.87

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2838: Matched controls
28380

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R06AX27

ATC

desloratadine; oral

5.2

307.7

1727

6575

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

8.7

307.7

961

1578

XQ800

NOMESCO Finland

Prick test

8.7

307.7

827

1275

L50.3

ICD-10 Finland

Dermatographic urticaria

58014.0

307.7

2800

L50.8

ICD-10 Finland

Other urticaria

78.8

307.7

303

R06AE09

ATC

levocetirizine; oral

5.3

307.7

1038

2807

L50.9

ICD-10 Finland

Urticaria, unspecified

29.2

307.7

525

219

C01CA24

ATC

epinephrine; parenteral

6.2

273.3

530

1012

R06AE07

ATC

cetirizine; oral

4.1

273.0

1980

10165

L50.0

ICD-10 Finland

Allergic urticaria

15.5

265.5

237

166

XQ802

NOMESCO Finland

Epicutan test

7.3

239.3

380

589

L50.1

ICD-10 Finland

Idiopathic urticaria

52.4

226.7

130

H02AB06

ATC

prednisolone; systemic

3.4

210.5

1770

9389

R03DC03

ATC

montelukast; oral

3.6

204.1

897

3202

T78.4

ICD-10 Finland

Allergy, unspecified

6.2

194.6

364

663

L30.9

ICD-10 Finland

Dermatitis, unspecified

3.4

193.6

968

3732

E0000UV, ,

ATC

3.1

191.1

1676

8935

L29.9

ICD-10 Finland

Pruritus, unspecified

8.0

178.3

254

346

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.5

156.4

435

1109

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

6.5

155.3

267

445

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

14.4

152.6

140

102

D07AC01

ATC

betamethasone; topical

2.7

147.7

1334

6937

L50.2

ICD-10 Finland

Urticaria due to cold and heat

76.0

137.6

R06AX22

ATC

ebastine; oral

2.9

133.9

813

3407

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

5.2

128.0

280

583

T78.3

ICD-10 Finland

Angioneurotic oedema

11.0

109.5

118

111

D07AB08

ATC

desonide; topical

3.2

105.8

489

1734

D07AB02

ATC

hydrocortisone butyrate; topical

2.4

101.6

1081

5823

E000001, ,

ATC

2.6

101.2

803

3785

D07AC13

ATC

mometasone; topical

2.3

95.1

1020

5482

R06AX13

ATC

loratadine; oral

2.6

93.6

684

3084

L50

ICD-10 Finland

Urticaria

6.9

89.1

141

214

L20.0

ICD-10 Finland

Besnier prurigo

3.1

87.6

412

1467

R03AC02

ATC

salbutamol; inhalant

2.2

81.7

1828

12911

D07AA02

ATC

hydrocortisone; topical

2.5

78.1

573

2566

E000002, ,

ATC

2.7

77.1

471

1926

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

74.3

883

4857

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

71.5

1268

8075

D07AD01

ATC

clobetasol; topical

2.4

69.0

585

2785

J45.9

ICD-10 Finland

Asthma, unspecified

2.3

66.8

659

3341

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

8.1

65.7

113

L29.8

ICD-10 Finland

Other pruritus

7.2

65.4

140

A02BA02

ATC

ranitidine; systemic

2.3

65.1

572

2758

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.7

63.9

391

1591

N02AX02

ATC

tramadol; systemic, rectal

1.9

62.4

1219

7922

A02BC05

ATC

esomeprazole; systemic

1.9

61.6

1235

8085

D02AX

ATC

Other emollients and protectives

4.3

60.5

162

394

TQW80

NOMESCO Finland

Local dermatologic skincare

5.2

60.4

128

257

R01AD09

ATC

mometasone; nasal

1.9

58.4

1527

10835

M25.5

ICD-10 Finland

Pain in joint

1.9

57.2

1074

6835

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

55.2

633

3378

L30.3

ICD-10 Finland

Infective dermatitis

4.1

54.5

156

399

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

54.1

1167

7732

J45

ICD-10 Finland

Asthma

2.4

52.2

395

1770

M54.5

ICD-10 Finland

Low back pain

1.8

51.7

1160

7749

R01AD08

ATC

fluticasone; nasal

1.9

51.3

973

6162

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.4

51.3

196

610

A02BC02

ATC

pantoprazole; systemic

1.9

51.0

1919

14970

R51.80

ICD-10 Finland

Headache

2.1

50.0

598

3230

N03AX12

ATC

[U] gabapentin; oral

2.2

49.9

521

2671

A02BC03

ATC

lansoprazole; oral

1.9

49.3

812

4902

D02AE01

ATC

carbamide; topical

2.9

48.8

248

911

L29

ICD-10 Finland

Pruritus

5.8

48.8

159

L28.1

ICD-10 Finland

Prurigo nodularis

10.4

48.5

H02AB07

ATC

prednisone; oral

2.3

48.4

419

1988

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

6.7

47.2

114

N06AX21

ATC

duloxetine; oral

2.2

46.7

439

2154

344

Kela drug reimbursment

Omalizumab

465.2

46.4

R06AX26

ATC

fexofenadine; oral

2.5

45.2

299

1255

R03BA05

ATC

fluticasone; inhalant

2.0

44.9

612

3450

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.4

44.8

341

1527

S98

ICPC

Urticaria

8.7

44.8

XQ820

NOMESCO Finland

Exposure to medicinal substance

11.7

44.8

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.5

44.7

295

1237

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

44.6

589

3282

H02AB04

ATC

methylprednisolone; systemic

2.2

44.2

451

2283

A92

ICPC

Allergy/allergic reaction NOS

3.5

44.2

155

456

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

43.9

998

6613

N03AX16

ATC

[U] pregabalin

1.9

43.8

682

4017

R01AD12

ATC

fluticasone furoate; nasal

1.8

43.2

1096

7486

L50.5

ICD-10 Finland

Cholinergic urticaria

+∞

42.8

M79.6

ICD-10 Finland

Pain in limb

1.7

42.2

1257

8965

G44.2

ICD-10 Finland

Tension-type headache

2.0

42.0

509

2746

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

41.4

1242

8859

J01AA02

ATC

doxycycline; systemic

1.9

41.3

2176

18138

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

5.1

41.0

175

7083A

ICD-9 Finland

Urticaria, Dermatographic urticaria

+∞

40.7

SPAT1263

SPAT

Sampling

1.7

40.6

1235

8828

M79.1

ICD-10 Finland

Myalgia

2.0

40.5

518

2846

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

40.2

566

3212

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.1

40.2

438

2269

A02BC01

ATC

omeprazole; systemic

1.8

39.8

760

4754

E000007, ,

ATC

2.7

39.8

224

867

J01FA10

ATC

azithromycin; systemic

1.7

39.5

1812

14408

UJF32

NOMESCO Finland

Coloscopy

1.9

39.3

667

4021

R03DX05

ATC

omalizumab; parenteral

392.8

39.2

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

39.1

177

609

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

7.3

39.0

R06.0

ICD-10 Finland

Dyspnoea

1.8

38.9

721

4465

J02AC01

ATC

fluconazole; systemic

1.7

38.6

1340

9877

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

37.9

1654

12913

ZXE00

NOMESCO Finland

One hour or less

1.7

37.9

1141

8092

M03BX02

ATC

tizanidine; oral

1.7

36.7

1838

14811

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

36.7

570

3333

S02

ICPC

Pruritus

3.2

36.6

146

466

E000006, ,

ATC

2.6

36.4

233

961

J01FF01

ATC

clindamycin; systemic

1.8

36.3

767

4924

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

36.2

834

5484

XQ801

NOMESCO Finland

Intracutantest

8.4

36.0

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

35.4

1245

9142

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

35.1

854

5692

N05BB01

ATC

hydroxyzine; systemic

2.6

34.9

222

912

N02BE01

ATC

paracetamol; systemic, rectal

2.1

34.5

2509

22288

R03BA01

ATC

beclometasone; inhalant

2.0

34.4

424

2288

J01FA06

ATC

roxithromycin; oral

1.6

34.3

1142

8250

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

34.3

651

4040

L23.8

ICD-10 Finland

Allergic contact dermatitis due to other agents

8.3

34.2

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.5

34.1

232

984

XQ848

NOMESCO Finland

Dermatological photography

3.8

34.0

106

288

R01AD58

ATC

fluticasone, combinations; nasal

1.7

33.8

855

5747

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

33.1

766

5022

R42

ICD-10 Finland

Dizziness and giddiness

1.8

33.0

601

3678

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.1

32.9

333

1669

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.0

32.9

154

539

R03BA02

ATC

budesonide; inhalant

1.8

32.9

559

3349

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

32.9

701

4491

M01AH05

ATC

etoricoxib; oral

1.6

32.6

1762

14255

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

32.6

231

998

J01DB01

ATC

cefalexin; oral

1.9

32.5

2365

20695

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

32.5

688

4397

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

32.4

284

1345

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

32.3

1162

8519

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.1

32.1

138

460

R03AK08

ATC

formoterol and beclometasone; inhalant

2.8

32.0

165

609

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

5.3

31.6

120

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.8

31.2

627

3942

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

4.0

30.9

233

R03BA08

ATC

ciclesonide; inhalant

2.2

30.8

296

1453

B86

ICD-10 Finland

Scabies

3.4

30.4

113

345

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

30.4

158

586

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

30.4

654

4189

UKC02

NOMESCO Finland

Cystoscopy

2.1

30.3

321

1636

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

30.3

273

1307

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

30.0

223

983

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

5.8

29.8

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

29.7

689

4500

J01FA09

ATC

clarithromycin; systemic

1.6

29.6

932

6581

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

29.4

714

4718

SPAT1312

SPAT

General health counselling

1.6

29.4

936

6624

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

29.4

286

1410

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

29.1

1111

8203

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

28.9

270

1310

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

28.9

407

2291

SPAT1301

SPAT

No procedures

1.6

28.7

824

5677

XKD00

NOMESCO Finland

Uroflowmetry

2.2

28.7

249

1172

S88

ICPC

Dermatitis contact/allergic

3.9

28.6

228

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

28.3

350

1884

D09AB01

ATC

zinc bandage without supplements; topical

4.5

28.1

153

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.9

28.0

414

2365

S29

ICPC

Skin symptom/complaint other

1.8

27.9

527

3243

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

27.9

2125

18295

C07AB07

ATC

bisoprolol; oral

1.6

27.9

1038

7602

XQ810

NOMESCO Finland

Physical test for urticaria

78.4

27.8

J01MA02

ATC

ciprofloxacin; systemic

1.6

26.8

943

6803

L30.8

ICD-10 Finland

Other specified dermatitis

3.3

26.6

103

323

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.2

26.4

234

1111

R13

ICD-10 Finland

Dysphagia

2.4

26.2

195

860

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

26.1

351

1941

R05

ICD-10 Finland

Cough

1.7

26.0

599

3886

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

26.0

657

4367

R53

ICD-10 Finland

Malaise and fatigue

1.6

25.9

692

4663

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

25.9

1180

8997

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

3.2

25.7

103

330

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.1

25.6

272

1385

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

25.5

389

2241

N02BF01

ATC

gabapentin; oral

2.1

25.4

252

1250

N06AX16

ATC

venlafaxine; oral

1.8

25.4

474

2900

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

25.4

251

1244

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.7

25.4

224

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.8

25.3

412

2421

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

25.2

302

1605

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

25.2

383

2203

R51

ICD-10 Finland

Headache

2.3

24.8

207

958

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

24.7

849

6067

A07AA02

ATC

nystatin; oral

2.5

24.5

164

689

SPAT1153

SPAT

Removal of sutures

1.6

24.4

747

5194

M54.2

ICD-10 Finland

Cervicalgia

2.1

24.4

257

1304

M79.7

ICD-10 Finland

Fibromyalgia

2.6

24.2

144

572

R02

ICPC

Shortness of breath/dyspnoea

1.9

24.1

335

1871

J01MA12

ATC

levofloxacin; systemic

1.8

24.0

431

2604

L30.0

ICD-10 Finland

Nummular dermatitis

2.9

23.9

117

420

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.8

23.9

386

2260

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

23.9

781

5509

K07.60

ICD-10 Finland

Snapping jaw

2.2

23.6

206

972

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

23.4

292

1572

UDC00

NOMESCO Finland

Ear microscopy

2.2

23.4

213

1022

Z3231

NOMESCO Finland

Registered nurse

1.6

23.3

691

4760

AA1AD

NOMESCO Finland

CT of head and brain

1.6

23.2

581

3841

L73.8

ICD-10 Finland

Other specified follicular disorders

5.1

23.1

N05BA04

ATC

oxazepam; oral

1.6

23.1

715

4975

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

23.1

372

2176

L03

ICPC

Low back symptom/complaint

1.6

23.1

801

5721

J46

ICD-10 Finland

Status asthmaticus

3.0

23.0

100

336

R60.0

ICD-10 Finland

Localized oedema

2.0

22.8

284

1528

K30

ICD-10 Finland

Functional dyspepsia

1.8

22.8

343

1964

X49

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

5.3

22.5

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

22.4

543

3554

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

22.4

242

1238

L04AD01

ATC

ciclosporin; systemic

3.8

22.3

187

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

22.0

214

1052

J01DA01

ATC

[U] cefalexin

1.5

22.0

1695

14204

J45.8

ICD-10 Finland

Mixed asthma

3.0

22.0

100

345

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

22.0

270

1446

P01AB01

ATC

metronidazole; oral, rectal

1.5

21.8

1151

8951

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

21.8

251

1314

A03FA02

ATC

cisapride; oral, rectal

2.2

21.8

188

882

R52.9

ICD-10 Finland

Pain, unspecified

1.9

21.6

274

1483

Z01.9

ICD-10 Finland

Special examination, unspecified

2.3

21.6

174

794

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.6

21.6

130

520

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

21.5

222

1117

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

3.6

21.5

206

R01AD01

ATC

beclometasone; nasal

1.7

21.4

448

2821

J30.3

ICD-10 Finland

Other allergic rhinitis

2.5

21.3

135

553

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

21.2

508

3311

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

21.1

168

762

L85.3

ICD-10 Finland

Xerosis cutis

5.5

21.0

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

3.5

21.0

214

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.2

20.9

178

830

L04AX03

ATC

methotrexate; systemic

1.9

20.9

278

1528

G50.1

ICD-10 Finland

Atypical facial pain

3.5

20.9

210

K08.80

ICD-10 Finland

Toothache NOS

1.9

20.8

296

1662

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

20.6

1554

12892

L20.8

ICD-10 Finland

Other atopic dermatitis

4.2

20.5

130

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.0

20.3

239

1260

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.2

20.2

172

802

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

20.2

360

2164

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.2

20.2

176

829

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

20.1

493

3231

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

20.0

163

747

L28.2

ICD-10 Finland

Other prurigo

7.8

19.6

XQ899

NOMESCO Finland

Other assessment of skin

7.4

19.5

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.9

19.4

266

1475

N06AX11

ATC

mirtazapine; oral

1.5

19.3

899

6781

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.9

19.2

266

1481

SPAT1260

SPAT

Consultation of another employee

1.6

19.1

452

2932

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

2.3

19.0

140

614

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.5

19.0

119

485

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

19.0

438

2823

R07.0

ICD-10 Finland

Pain in throat

1.9

18.9

237

1276

R52.2

ICD-10 Finland

Other chronic pain

2.5

18.9

121

498

R03AC03

ATC

terbutaline; inhalant

1.7

18.8

400

2523

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

18.8

959

7353

L12

ICPC

Hand/finger symptom/complaint

1.6

18.6

453

2958

M01AC06

ATC

meloxicam; systemic, rectal

1.5

18.6

911

6929

WZC30

NOMESCO Finland

Teaching

1.7

18.6

383

2396

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.7

18.5

368

2278

A02BC04

ATC

rabeprazole; oral

1.9

18.5

260

1453

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

18.5

343

2085

R03AC13

ATC

formoterol; inhalant

2.3

18.4

141

630

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

18.3

240

1311

WX402

NOMESCO Finland

General anaesthesia

1.6

18.3

569

3933

R96

ICPC

Asthma

1.9

18.3

265

1496

G47.3

ICD-10 Finland

Sleep apnoea

1.6

18.2

517

3500

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.2

18.2

224

R06.4

ICD-10 Finland

Hyperventilation

3.6

18.2

170

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

18.2

1336

10932

R50.9

ICD-10 Finland

Fever, unspecified

1.7

18.1

381

2395

M01AB05

ATC

diclofenac; systemic, rectal

1.4

18.0

1769

15224

R00.2

ICD-10 Finland

Palpitations

1.9

18.0

244

1348

G43.3

ICD-10 Finland

Complicated migraine

3.0

17.9

279

P01BA02

ATC

hydroxychloroquine; oral

1.9

17.6

235

1292

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

17.5

237

1308

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.6

17.5

101

396

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

17.4

282

1647

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

17.4

756

5604

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

4.5

17.3

L01

ICPC

Neck symptom/complaint

1.6

17.3

461

3074

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

17.1

861

6559

L53.9

ICD-10 Finland

Erythematous condition, unspecified

4.9

17.1

N06AA09

ATC

amitriptyline; systemic

1.9

17.1

238

1327

J01EA01

ATC

trimethoprim; systemic

1.5

17.1

722

5319

L08

ICPC

Shoulder symptom/complaint

1.5

17.0

540

3744

ZXA10

NOMESCO Finland

Bilateral

1.6

17.0

427

2804

SFA10

NOMESCO Finland

One-surface restoration

1.4

17.0

1553

13132

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

16.9

259

1487

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.8

16.9

294

S18

ICPC

Laceration/cut

1.4

16.9

1067

8467

M54.6

ICD-10 Finland

Pain in thoracic spine

1.9

16.8

228

1259

M01AH01

ATC

celecoxib; oral

1.6

16.8

417

2731

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

16.8

343

2138

M01AE02

ATC

naproxen; oral, rectal

1.4

16.8

1596

13578

A01AB09

ATC

miconazole; local oral

1.9

16.7

219

1196

J01DA09

ATC

[U] cefadroxil

1.5

16.7

714

5265

J20

ICD-10 Finland

Acute bronchitis

1.8

16.7

278

1637

L17

ICPC

Foot/toe symptom/complaint

1.5

16.6

723

5349

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.9

16.6

221

1215

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

16.5

156

759

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

16.4

755

5644

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

16.4

1445

12112

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

16.3

282

1677

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

16.3

870

6686

L71.9

ICD-10 Finland

Rosacea, unspecified

2.7

16.3

328

H02AB09

ATC

hydrocortisone; systemic

2.9

16.2

273

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

16.1

183

953

SFA20

NOMESCO Finland

Two-surface restoration

1.4

16.1

1648

14150

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

16.1

246

1412

SPAT1310

SPAT

Counselling related to known health issue

1.4

15.9

818

6240

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.9

15.8

260

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

15.7

159

794

H03AA01

ATC

levothyroxine sodium; systemic

1.5

15.7

634

4616

R03AC12

ATC

salmeterol; inhalant

2.4

15.7

109

467

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

15.7

281

1689

C07AA05

ATC

propranolol; systemic

1.5

15.6

595

4280

D07CC01

ATC

betamethasone and antibiotics; topical

1.7

15.6

335

2114

N02BF02

ATC

pregabalin; oral

2.0

15.6

162

817

M02AA07

ATC

piroxicam; topical

1.4

15.4

813

6224

D11AH01

ATC

tacrolimus; topical

3.9

15.4

113

R01AD05

ATC

budesonide; nasal

1.8

15.4

219

1229

M54

ICD-10 Finland

Dorsalgia

1.6

15.3

363

2349

L27.2

ICD-10 Finland

Dermatitis due to ingested food

4.3

15.3

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.7

15.2

305

R03BB04

ATC

tiotropium bromide; inhalant

1.9

15.1

202

1111

E000003, ,

ATC

2.2

15.1

129

604

J05AB01

ATC

aciclovir; systemic

1.5

15.0

593

4295

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

14.8

253

1499

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.9

14.8

248

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

14.7

361

2354

Z01.2

ICD-10 Finland

Dental examination

1.4

14.7

1290

10736

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

14.7

213

1202

D01

ICPC

Abdominal pain/cramps general

1.6

14.7

347

2242

R01AD11

ATC

triamcinolone; nasal

1.8

14.7

247

1458

J01FA01

ATC

erythromycin; systemic

1.6

14.6

417

2817

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

14.4

236

1383

X58

ICD-10 Finland

Exposure to other specified factors

1.6

14.3

364

2392

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.0

14.2

160

831

J01MA14

ATC

moxifloxacin; systemic

1.8

14.2

208

1178

L56.4

ICD-10 Finland

Polymorphous light eruption

5.7

14.1

R05

ICPC

Cough

1.4

14.0

635

4713

UJF92

NOMESCO Finland

Capsular endoscopy

2.8

14.0

239

WX290

NOMESCO Finland

Other blockage of nerve

1.4

14.0

1379

11655

K02.1

ICD-10 Finland

Caries of dentine

1.4

13.9

1666

14498

R21

ICPC

Throat symptom/complaint

1.4

13.9

672

5046

D07BC01

ATC

betamethasone and antiseptics; topical

1.7

13.9

286

1782

J01AA07

ATC

tetracycline; systemic

1.5

13.9

443

3063

S06.0

ICD-10 Finland

Concussion

1.7

13.9

271

1665

M01AX17

ATC

nimesulide; oral

1.5

13.9

508

3617

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

13.8

362

2396

L15

ICPC

Knee symptom/complaint

1.5

13.8

591

4341

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

13.8

353

2325

L71.8

ICD-10 Finland

Other rosacea

3.0

13.7

198

A01

ICPC

Pain general/multiple sites

1.8

13.7

231

1363

SPAT1058

SPAT

PEF monitoring instruction

1.8

13.7

197

1109

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

13.7

241

1441

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

13.6

1176

9724

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

13.6

196

1105

L28.0

ICD-10 Finland

Lichen simplex chronicus

4.1

13.5

J32.4

ICD-10 Finland

Chronic pansinusitis

3.2

13.4

169

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

13.4

428

2959

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

13.4

669

5053

SPAT1210

SPAT

Application of cast or individual aid

2.2

13.3

116

547

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

13.3

264

1629

L20

ICD-10 Finland

Atopic dermatitis

2.3

13.3

105

476

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

13.3

1984

17811

N05CF01

ATC

zopiclone; oral

1.4

13.3

727

5578

R03BC03

ATC

nedocromil; inhalant

1.9

13.2

178

982

D02

ICPC

Abdominal pain epigastric

1.9

13.2

172

939

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

13.2

256

1572

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

13.1

942

7557

C07AB02

ATC

metoprolol; systemic

1.6

13.1

369

2483

OAB93, ,

SPAT

1.8

13.0

201

1157

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.4

13.0

355

A01AB04

ATC

amphotericin B; local oral

2.2

13.0

107

494

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.9

13.0

157

836

J04BA02

ATC

dapsone; oral

5.2

13.0

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

12.9

716

5499

M03AX01

ATC

botulinum toxin; parenteral

3.0

12.9

184

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.1

12.9

127

629

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.8

12.8

188

1064

G04BD08

ATC

solifenacin; oral

2.0

12.8

132

664

L43.9

ICD-10 Finland

Lichen planus, unspecified

2.9

12.8

206

ZXD05

NOMESCO Finland

Urgent procedure

1.4

12.8

772

6015

S01

ICPC

Pain/tenderness of skin

2.1

12.8

121

590

J01AA04

ATC

lymecycline; systemic

1.5

12.7

387

2650

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

12.6

1923

17233

70891

ICD-8 Finland

Urticaria, Recidivans, Chronica

+∞

12.5

D07XC01

ATC

betamethasone; topical

1.6

12.5

269

1696

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

12.5

204

1193

SPAT1211

SPAT

Application of soft bandage

1.7

12.4

212

1255

K80

ICPC

Cardiac arrhythmia NOS

1.8

12.4

189

1083

S87

ICPC

Dermatitis/atopic eczema

2.5

12.4

326

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.2

12.4

104

484

XKC03

NOMESCO Finland

Water cystometry

2.5

12.3

291

N05CF02

ATC

zolpidem; oral

1.5

12.3

447

3172

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

12.3

685

5261

T78.0

ICD-10 Finland

Anaphylactic shock due to adverse food reaction

14.4

12.3

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

12.3

271

1720

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

12.2

153

824

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

12.2

111

533

R30.0

ICD-10 Finland

Dysuria

2.1

12.2

117

574

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

4.9

12.2

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

12.1

211

1256

H01

ICPC

Ear pain/earache

1.6

12.1

326

2168

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

12.1

240

1481

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.7

12.0

235

1444

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

2.1

12.0

119

590

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.4

12.0

349

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

12.0

959

7795

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

11.9

127

647

N05AH04

ATC

quetiapine; oral

1.5

11.9

471

3397

R03DC01

ATC

zafirlukast; oral

3.2

11.9

140

D06BX01

ATC

metronidazole; topical

1.6

11.9

297

1943

R52.0

ICD-10 Finland

Acute pain

2.2

11.9

103

486

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

11.8

183

1053

M25.2

ICD-10 Finland

Flail joint

3.2

11.8

141

S21

ICPC

Skin texture symptom/complaint

1.6

11.7

331

2225

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

11.7

551

4103

H57.1

ICD-10 Finland

Ocular pain

2.1

11.7

113

556

KMAK, ,

NOMESCO Finland

1.3

11.6

1431

12358

J01FA15

ATC

telithromycin; oral

1.6

11.6

260

1655

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.8

11.6

201

U07

ICPC

Urine symptom/complaint other

1.8

11.5

167

942

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.5

11.5

113

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

11.5

129

669

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.8

11.5

213

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

11.5

477

3470

SPAT1097

SPAT

Recording of ECG

1.6

11.5

290

1900

-, ,

ICD-10 Finland

2.8

11.5

202

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

5.7

11.5

TLC02

NOMESCO Finland

Simple extraction of IUD

1.9

11.5

146

791

N01

ICPC

Headache

1.5

11.5

354

2427

R51.81

ICD-10 Finland

Facial pain NOS

2.4

11.4

314

C09CA06

ATC

candesartan; oral

1.4

11.4

541

4033

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

11.4

283

1848

C05AA08

ATC

fluocortolone; rectal, topical

1.6

11.4

312

2084

SFA30

NOMESCO Finland

Three-surface restoration

1.3

11.3

1058

8783

N76.0

ICD-10 Finland

Acute vaginitis

1.7

11.3

234

1461

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

11.3

435

3121

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

11.2

601

4574

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

11.2

127

662

K03.80

ICD-10 Finland

Irradiated enamel

1.8

11.2

171

981

A01AB10

ATC

natamycin; local oral

2.3

11.1

387

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.8

11.1

162

916

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

11.1

156

872

SPAT1238

SPAT

Brief therapy

2.5

11.1

264

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.9

11.1

184

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

11.1

473

N06AX26

ATC

vortioxetine; oral

1.7

11.0

213

1305

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

11.0

600

4578

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

11.0

184

1084

GD1AA, ,

SPAT

1.5

11.0

344

2366

L24.9

ICD-10 Finland

Irritant contact dermatitis, unspecified cause

4.7

10.9

N04BC05

ATC

pramipexole; oral

1.8

10.8

165

946

G43

ICD-10 Finland

Migraine

1.7

10.7

187

1115

D11AH02

ATC

pimecrolimus; topical

4.6

10.7

J01CA04

ATC

amoxicillin; systemic

1.4

10.7

2285

21232

J02AC02

ATC

itraconazole; systemic

1.4

10.7

437

3169

WZA10

NOMESCO Finland

Extensive medical or dental certificate

3.0

10.7

150

M54.3

ICD-10 Finland

Sciatica

1.8

10.6

150

840

R39.1

ICD-10 Finland

Other difficulties with micturition

2.6

10.6

234

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

10.6

457

3344

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

10.6

1077

9020

SPAT1101

SPAT

Orthostatic test

2.4

10.6

319

M23.8

ICD-10 Finland

Other internal derangements of knee

2.1

10.6

104

515

L04AX01

ATC

azathioprine; systemic

2.0

10.6

108

543

1220

FHL

Arthroscopy

2.2

10.5

423

J01MA01

ATC

ofloxacin; systemic

1.8

10.5

169

985

J34.2

ICD-10 Finland

Deviated nasal septum

1.9

10.5

122

642

N06AX12

ATC

bupropion; oral

1.6

10.5

220

1378

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

10.5

607

4676

Z3226

NOMESCO Finland

Physiotherapist

1.5

10.5

418

3016

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.5

10.4

260

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

10.4

246

1586

WYA10

NOMESCO Finland

Emergency care or similar visit

1.7

10.4

207

1279

J01DA06

ATC

[U] cefuroxime

1.5

10.4

356

2493

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

10.4

277

1839

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

10.4

472

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

10.3

462

3403

B35.3

ICD-10 Finland

Tinea pedis

2.0

10.3

111

568

R35

ICD-10 Finland

Polyuria

1.9

10.3

127

681

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.7

10.3

197

L29.0

ICD-10 Finland

Pruritus ani

3.5

10.3

K11.2

ICD-10 Finland

Sialoadenitis

2.2

10.3

420

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

10.3

321

2205

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.2

10.3

122

A03

ICPC

Fever

1.4

10.3

478

3547

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

10.2

240

1546

R52.1

ICD-10 Finland

Chronic intractable pain

3.6

10.2

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.4

10.2

275

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.2

10.2

363

Z00.8

ICD-10 Finland

Other general examinations

1.7

10.2

199

1224

J01MA06

ATC

norfloxacin; oral

1.5

10.1

315

2161

XX9TE

NOMESCO Finland

Compementary ultrasound examination

4.2

10.1

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

10.1

825

6694

SAA04

NOMESCO Finland

Special examination of mouth

1.8

10.0

141

789

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.5

10.0

259

B02AA02

ATC

tranexamic acid; systemic

1.4

10.0

436

3195

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

10.0

1087

9166

R68.2

ICD-10 Finland

Dry mouth, unspecified

4.5

10.0

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

10.0

134

739

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.6

10.0

212

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.3

10.0

114

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

10.0

353

2487

G54.0

ICD-10 Finland

Brachial plexus disorders

2.2

10.0

399

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

9.9

748

5992

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

1.9

9.9

131

719

M48.0

ICD-10 Finland

Spinal stenosis

1.6

9.9

215

1358

A02BA04

ATC

nizatidine; systemic

1.8

9.9

143

807

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.4

9.9

279

N06AB04

ATC

citalopram; systemic

1.4

9.9

510

3850

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

9.9

165

972

N06AB05

ATC

paroxetine; oral

1.8

9.9

161

942

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.3

9.8

305

N03AE01

ATC

clonazepam; systemic

1.9

9.8

132

729

SCA02

NOMESCO Finland

Preventive oral health care

1.5

9.8

291

1977

N02AJ13

ATC

tramadol and paracetamol; systemic

2.5

9.8

244

S02.51

ICD-10 Finland

Fracture of tooth, open

1.6

9.8

234

1514

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

9.8

141

796

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.4

9.8

287

D06

ICPC

Abdominal pain localized other

1.6

9.7

232

1499

DHB50

NOMESCO Finland

Turbinoplasty

2.2

9.7

344

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.8

9.7

164

R06.2

ICD-10 Finland

Wheezing

1.9

9.7

114

603

A07EA06

ATC

budesonide; oral, local oral

2.0

9.7

478

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

9.6

842

6885

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.8

9.6

143

815

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.0

9.6

493

J01DC02

ATC

cefuroxime; systemic

1.8

9.6

147

845

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

9.6

167

996

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

9.5

269

1809

M35.7

ICD-10 Finland

Hypermobility syndrome

2.5

9.5

230

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.3

9.4

285

N06AB10

ATC

escitalopram; oral

1.4

9.4

584

4540

N05BA01

ATC

diazepam; systemic, rectal

1.5

9.4

293

2011

M54.1

ICD-10 Finland

Radiculopathy

2.0

9.4

504

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.3

9.3

318

-1, ,

ICD-10 Finland

1.8

9.3

146

844

JAH01

NOMESCO Finland

Laparoscopy

1.8

9.3

125

690

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

9.3

365

2623

R11

ICD-10 Finland

Nausea and vomiting

1.6

9.3

216

1388

A06AC51

ATC

ispaghula, combinations; oral

1.9

9.3

114

612

M01AH02

ATC

rofecoxib; oral

1.6

9.3

247

1639

SPAT1262

SPAT

Handing over of treatment supplies

1.5

9.2

335

2371

J01

ICD-10 Finland

Acute sinusitis

1.7

9.2

166

999

E000004, ,

ATC

2.5

9.2

239

K29.7

ICD-10 Finland

Gastritis, unspecified

2.1

9.2

392

S01GX02

ATC

levocabastine; ophthalmic

1.7

9.2

167

1008

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.4

9.2

258

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

9.2

268

1815

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

9.1

355

2545

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

9.1

458

3437

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

9.1

963

8064

C10AC01

ATC

colestyramine; oral

2.3

9.1

315

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.7

9.1

156

926

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

9.1

1482

13102

N03AX11

ATC

topiramate; oral

2.1

9.1

394

N02AA05

ATC

oxycodone; systemic

1.5

9.1

301

2093

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.2

9.0

106

WX723

NOMESCO Finland

CPAP therapy

2.0

9.0

477

R07.3

ICD-10 Finland

Other chest pain

1.6

9.0

225

1471

WX780

NOMESCO Finland

Remote monitoring CPAP

2.0

9.0

512

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

9.0

320

2256

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

9.0

153

907

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.1

9.0

430

C03CA01

ATC

furosemide; systemic

1.4

9.0

442

3308

SPAT1254

SPAT

Administration of medicine

1.5

8.9

317

2233

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.2

8.9

357

SPAT1229

SPAT

Assessment of need for aid

1.8

8.9

140

811

L21.0

ICD-10 Finland

Seborrhoea capitis

3.4

8.9

E0001A1, ,

ATC

2.3

8.9

287

WX320

NOMESCO Finland

Spinalanesthesy

1.4

8.9

531

4101

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

8.9

152

903

SPAT1139

SPAT

Nutrition survey

2.1

8.8

365

L18

ICPC

Muscle pain

1.9

8.8

104

551

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

8.8

203

1303

KH1AD

NOMESCO Finland

CT of urinary organs

2.2

8.8

353

L85.81

ICD-10 Finland

Keratosis pilaris

9.5

8.8

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.0

8.7

483

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.1

8.6

109

N30.0

ICD-10 Finland

Acute cystitis

1.4

8.6

420

3134

K13.78

ICD-10 Finland

Other change in the oral mucosa

2.3

8.6

259

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.6

8.6

212

1381

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

8.6

211

1373

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

8.6

113

620

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

8.6

154

926

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

8.6

173

1073

A03CA02

ATC

clidinium and psycholeptics; oral

1.9

8.6

111

606

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

8.6

330

2361

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.1

8.6

363

J35.0

ICD-10 Finland

Chronic tonsillitis

1.6

8.6

174

1082

D01AE15

ATC

terbinafine; topical

1.8

8.5

135

784

G01AF04

ATC

miconazole; vaginal

1.8

8.5

135

784

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.1

8.5

110

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

8.5

421

3150

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.8

8.5

122

688

G01AF05

ATC

econazole; vaginal

1.6

8.5

223

1474

M54.8

ICD-10 Finland

Other dorsalgia

1.8

8.5

120

674

XQ832

NOMESCO Finland

Other provocation test

27.6

8.5

H92.0

ICD-10 Finland

Otalgia

1.7

8.5

168

1038

C10AA03

ATC

pravastatin; oral

1.9

8.5

111

609

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

8.5

214

1403

S80.0

ICD-10 Finland

Contusion of knee

1.6

8.5

195

1251

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

8.4

100

531

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.8

8.4

133

772

N06AB06

ATC

sertraline; oral

1.5

8.4

311

2208

-1, ,

NOMESCO Finland

1.3

8.4

904

7572

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.5

8.4

195

K04

ICPC

Palpitations/awareness of heart

1.8

8.4

129

743

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.2

8.4

320

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

8.4

252

1716

K59.0

ICD-10 Finland

Constipation

1.8

8.4

118

662

WIX00

NOMESCO Finland

Allergy cleanup guidance

12.8

8.4

L83

ICPC

Neck syndrome

3.3

8.3

B01AB05

ATC

enoxaparin; parenteral

1.3

8.3

672

5417

M77.1

ICD-10 Finland

Lateral epicondylitis

1.6

8.3

208

1360

B07.9

ICD-10 Finland

Verruca simplex

2.0

8.3

484

ZX120

NOMESCO Finland

Intravenous

1.6

8.3

200

1296

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.3

8.3

251

L02

ICPC

Back symptom/complaint

1.5

8.3

267

1844

WQ000

NOMESCO Finland

Hyposensibilisation

3.6

8.3

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.0

8.3

464

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

8.2

436

3299

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

8.2

183

1164

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

8.2

275

1916

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

8.2

109

601

R10.0

ICD-10 Finland

Acute abdomen

2.0

8.1

425

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

8.1

1122

9678

R06.5

ICD-10 Finland

Mouth breathing

1.6

8.1

194

1256

ZX112

NOMESCO Finland

Subcutaneous

2.4

8.1

229

R55

ICD-10 Finland

Syncope and collapse

1.6

8.1

198

1289

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

8.1

221

1475

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.5

8.1

205

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.4

8.0

236

A07EA02

ATC

hydrocortisone; rectal

2.4

8.0

224

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

8.0

146

883

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

2.5

8.0

200

R49.01

ICD-10 Finland

Functional dysphonia

2.0

8.0

408

PA6AD

NOMESCO Finland

CT of neck arteries

2.3

7.9

263

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.5

7.9

201

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

7.9

500

U02

ICPC

Urinary frequency/urgency

1.4

7.9

344

2518

H93.1

ICD-10 Finland

Tinnitus

1.7

7.9

152

933

R76.0

ICD-10 Finland

Raised antibody titre

6.6

7.9

N17

ICPC

Vertigo/dizziness

1.5

7.9

259

1798

L43.8

ICD-10 Finland

Other lichen planus

2.6

7.9

166

M01AB08

ATC

etodolac; oral

1.6

7.8

161

1004

G04CA02

ATC

tamsulosin; oral

1.5

7.8

237

1616

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

6.1

7.8

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.5

7.8

202

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.2

7.8

284

R06AX18

ATC

acrivastine; oral

2.1

7.8

350

L86

ICPC

Back syndrome with radiating pain

1.7

7.8

138

828

R25.2

ICD-10 Finland

Cramp and spasm

2.3

7.8

265

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

7.8

154

952

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

7.7

415

3145

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

7.7

234

1596

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

7.7

392

F01

ICPC

Eye pain

2.1

7.7

365

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.1

7.7

325

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.6

7.7

165

1041

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.8

7.7

107

599

D93

ICPC

Irritable bowel syndrome

2.6

7.7

168

L01BA01

ATC

methotrexate; systemic

1.9

7.6

449

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

7.6

296

2120

DJD20

NOMESCO Finland

Plastic repair of septum of nose

2.0

7.6

387

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

7.6

242

1668

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

7.6

230

1569

M01AX05

ATC

glucosamine; oral

1.4

7.6

336

2465

OAB50, ,

SPAT

1.8

7.6

109

616

K03.00

ICD-10 Finland

Approximal wear

1.6

7.6

175

1124

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

7.6

258

1803

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

7.6

138

835

A46

ICD-10 Finland

Erysipelas

1.5

7.6

244

1687

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.4

7.5

218

I84.4

ICD-10 Finland

External hemorrhoids with other complications

2.8

7.5

124

R03BB01

ATC

ipratropium bromide; inhalant

2.1

7.5

302

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.6

7.5

184

1199

J01CA08

ATC

pivmecillinam; oral

1.2

7.5

1186

10364

N30

ICD-10 Finland

Cystitis

1.5

7.5

224

1525

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

2.0

7.5

356

H29

ICPC

Ear symptom/complaint other

1.5

7.4

237

1634

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

7.4

266

1877

R30.9

ICD-10 Finland

Painful micturition, unspecified

3.6

7.4

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.2

7.4

258

R12

ICD-10 Finland

Heartburn

1.6

7.3

189

1245

G03DC03

ATC

lynestrenol; oral

2.0

7.3

352

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

3.1

7.3

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.2

7.3

279

7088A

ICD-9 Finland

Urticaria, Other specified urticaria[URTICARIA CHRONICA NUD]

+∞

7.3

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

+∞

7.3

7088B

ICD-9 Finland

Urticaria, Other specified urticaria[URTICARIA RECURRENS NUD]

+∞

7.3

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

7.3

450

R49.09

ICD-10 Finland

Unspecified dysphonia

2.9

7.3

110

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

7.3

165

1056

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.3

7.3

222

R74

ICPC

Upper respiratory infection acute

1.3

7.2

937

7994

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.7

7.2

129

776

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

3.0

7.2

105

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.1

7.2

300

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

7.2

190

1259

A07AA09

ATC

vancomycin; oral

3.0

7.2

100

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.3

7.2

242

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

7.2

304

2214

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

7.1

292

2112

R09

ICPC

Sinus symptom/complaint

1.5

7.1

239

1665

D11

ICPC

Diarrhoea

1.4

7.1

318

2337

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.9

7.1

475

A07EC02

ATC

mesalazine; oral, rectal

1.7

7.1

123

734

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.5

7.1

206

1393

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

6.6

7.1

M02AA10

ATC

ketoprofen; topical

1.4

7.1

331

2451

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

7.1

310

2270

C01DA14

ATC

isosorbide mononitrate; oral

1.6

7.1

175

1143

R03DA04

ATC

theophylline; systemic, rectal

1.9

7.1

469

ZY010

NOMESCO Finland

Hospital outpatient

1.6

7.0

140

867

S01GX08

ATC

ketotifen; ophthalmic

1.7

7.0

126

759

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.4

7.0

268

1914

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.7

7.0

135

829

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.5

7.0

164

T82

ICPC

Obesity

1.7

7.0

112

654

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

2.3

7.0

232

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

3.5

7.0

M15

ICD-10 Finland

Polyarthrosis

1.8

7.0

102

580

SPAT1377

SPAT

Polysomnography

1.9

7.0

407

Z01.7

ICD-10 Finland

Laboratory examination

1.4

7.0

346

2588

R07

ICPC

Sneezing/nasal congestion

1.5

7.0

187

1244

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.6

7.0

162

1043

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

7.0

165

1067

L04AA13

ATC

[U] leflunomide

2.1

7.0

278

A04

ICPC

Weakness/tiredness general

1.4

7.0

350

2624

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.8

6.9

508

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

6.9

695

5748

H81.3

ICD-10 Finland

Other peripheral vertigo

2.1

6.9

279

ACC51

NOMESCO Finland

Release of median nerve

1.6

6.9

175

1150

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

6.9

158

1014

L14

ICPC

Leg/thigh symptom/complaint

1.6

6.9

168

1094

K05.09

ICD-10 Finland

Acute gingivitis, UNS

2.4

6.9

190

Z2445

NOMESCO Finland

Psychologist

1.8

6.9

104

598

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

1.8

6.9

517

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

2.9

6.8

103

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

6.8

138

858

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.8

6.8

562

J04.0

ICD-10 Finland

Acute laryngitis

1.7

6.8

110

644

H10

ICD-10 Finland

Conjunctivitis

1.5

6.8

200

1356

WX002

NOMESCO Finland

Sedation and analgesia

1.4

6.8

390

2984

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

6.8

120

721

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.7

6.8

120

721

U05

ICPC

Urination problems other

1.8

6.8

483

T88.6

ICD-10 Finland

Anaphylactic shock due to adverse effect of correct drug or medicament properly administered

6.1

6.8

L66.9

ICD-10 Finland

Cicatricial alopecia, unspecified

16.7

6.7

XQ818

NOMESCO Finland

Conjunctival allergen provocation test

16.7

6.7

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

6.7

269

1938

I73.0

ICD-10 Finland

Raynaud syndrome

2.3

6.7

217

SPAT1240

SPAT

Therapeutic discussion

1.4

6.7

303

2230

A98

ICPC

Health maint/preventive medicine

1.8

6.7

2759

26963

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

6.7

244

1727

D10AX03

ATC

azelaic acid; topical

1.5

6.7

228

1593

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

6.7

565

L28

ICD-10 Finland

Lichen simplex chronicus and prurigo

3.5

6.7

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.7

6.7

107

625

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

3.4

6.7

XQ845

NOMESCO Finland

Dermatoscopy

2.6

6.7

150

C09CA01

ATC

losartan; oral

1.3

6.7

453

3554

D05BB02

ATC

acitretin; oral

2.4

6.7

174

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

6.7

130

801

D06AX01

ATC

fusidic acid; topical

1.5

6.7

219

1520

L13

ICPC

Hip symptom/complaint

1.4

6.7

373

2844

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.9

6.7

407

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

6.6

170

1119

Z00.0

ICD-10 Finland

General medical examination

1.3

6.6

432

3369

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

6.6

595

4848

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.2

6.6

244

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.8

6.6

567

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

6.6

174

1152

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

6.6

472

F45.0

ICD-10 Finland

Somatization disorder

4.0

6.6

L60.0

ICD-10 Finland

Ingrowing nail

1.7

6.6

112

665

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.7

6.6

111

658

L16

ICPC

Ankle symptom/complaint

1.4

6.6

281

2048

N41.9

ICD-10 Finland

Inflammatory disease of prostate, unspecified

3.6

6.6

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

6.6

120

727

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

6.6

605

4945

N02CC04

ATC

rizatriptan; oral

1.5

6.6

169

1114

-54

ICPC

Repair/fix-suture/cast/prosth device

2.3

6.6

213

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

6.6

346

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.4

6.5

317

2361

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

3.3

6.5

J05AB11

ATC

valaciclovir; oral

1.4

6.5

339

2553

N94.1

ICD-10 Finland

Dyspareunia

2.2

6.5

239

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.7

6.5

122

744

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

6.5

467

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.4

6.5

176

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.2

6.5

220

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.3

6.5

201

D10BA01

ATC

isotretinoin; oral

1.5

6.5

190

1288

M23

ICD-10 Finland

Internal derangement of knee

2.0

6.5

313

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.3

6.5

214

G44.8

ICD-10 Finland

Other specified headache syndromes

2.3

6.5

214

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.8

6.5

519

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.7

6.5

118

715

R4110

NOMESCO Finland

Physiotherapy

1.3

6.5

591

4827

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.7

6.4

112

670

L04AA06

ATC

mycophenolic acid; systemic

2.4

6.4

171

S01XA18

ATC

ciclosporin; ophthalmic

3.3

6.4

N63

ICD-10 Finland

Unspecified lump in breast

1.5

6.4

179

1202

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.0

6.4

322

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.0

6.4

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

6.4

158

1033

L70.0

ICD-10 Finland

Acne vulgaris

1.8

6.4

478

M77.4

ICD-10 Finland

Metatarsalgia

1.6

6.3

151

978

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.9

6.3

400

K05.0

ICD-10 Finland

Acute gingivitis

2.0

6.3

337

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.2

6.3

A06AD11

ATC

lactulose; oral

1.4

6.3

244

1748

R33

ICD-10 Finland

Retention of urine

1.7

6.3

576

A02BA03

ATC

famotidine; systemic

2.0

6.3

303

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

6.3

230

1630

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.4

6.3

336

2543

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

3.4

6.3

WX204

NOMESCO Finland

Axillary plexus blockaced

1.9

6.3

380

WXQ26

NOMESCO Finland

UVB broad spectrum light therapy

+∞

6.3

Z71.8

ICD-10 Finland

Other specified counselling

1.2

6.2

789

6692

R03AK11

ATC

formoterol and fluticasone; inhalant

2.0

6.2

318

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.2

6.2

212

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.2

6.2

225

XX3DW

NOMESCO Finland

Time consuming IT work

1.5

6.2

212

1484

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

3.1

6.2

G03DC05

ATC

[U] tibolone

1.8

6.2

439

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

2.0

6.2

333

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.0

6.2

340

TAB00

NOMESCO Finland

Lumbar puncture

1.7

6.2

108

648

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

6.2

207

1444

L56.3

ICD-10 Finland

Solar urticaria

7.7

6.1

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

6.1

133

844

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.5

6.1

145

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.5

6.1

145

S50.0

ICD-10 Finland

Contusion of elbow

1.9

6.1

405

B34.9

ICD-10 Finland

Viral infection, unspecified

1.9

6.1

405

N06AA10

ATC

nortriptyline; systemic

2.1

6.1

253

L57.0

ICD-10 Finland

Actinic keratosis

1.6

6.1

154

1012

EMB10

NOMESCO Finland

Tonsillectomy

1.5

6.1

170

1142

L98.1

ICD-10 Finland

Factitial dermatitis

12.5

6.1

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

6.1

493

M22.4

ICD-10 Finland

Chondromalacia patellae

1.8

6.1

471

R06AX11

ATC

astemizole; oral

1.9

6.1

413

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.5

6.1

180

1225

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.5

6.0

183

1250

U01

ICPC

Dysuria/painful urination

1.5

6.0

197

1366

ULA02

NOMESCO Finland

Kolposcopy

1.4

6.0

286

2124

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

3.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005322) IgE [Units/volume] in Serum or Plasma

684

1664

5.10

268.99

1.6

1.3

248.43

188.41

u/ml

1.21

650

1538

(3019420) Tryptase [Mass/volume] in Serum or Plasma

131

106

12.91

134.11

1.4

1.6

5.47

8.01

ug/l

0.89

119

(40760892) CBC W Ordered Manual Differential panel - Blood

1736

10930

2.52

120.54

7.6

6.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

32.51

117.71

1.1

1.0

0.37

0.01

u/ml

0.49

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

105

14.31

114.65

1.2

0.30

0.29

g/l

0.29

(3001604) Monocytes [#/volume] in Blood

1784

11632

2.44

110.64

6.7

5.7

0.54

0.55

e9/l

0.77

1609

10169

(3006315) Basophils [#/volume] in Blood

1785

11649

2.43

110.36

6.7

5.7

0.04

e9/l

1.13

1610

10170

(3013115) Eosinophils [#/volume] in Blood

1823

12077

2.42

107.87

6.9

5.9

0.21

0.18

e9/l

7.48

1675

10711

(3037522) Nuclear Ab [Titer] in Serum

764

3445

2.67

106.10

1.6

1.3

521.63

561.29

titre

0.22

147

711

(3019198) Lymphocytes [#/volume] in Blood

1804

12045

2.37

102.53

6.8

5.7

2.01

1.96

e9/l

0.45

1660

10798

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

13.66

100.08

1.2

108.40

106.82

0.17

(3013707) Erythrocyte sedimentation rate by Westergren method

2291

17209

2.72

97.66

5.2

3.8

10.18

10.71

mm/h

1.30

2159

16048

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

280

727

4.16

96.67

1.6

1.8

1.18

1.17

g/l

0.19

261

685

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

274

701

4.22

96.48

1.7

1.8

0.23

g/l

0.08

254

660

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

109

110

10.26

96.25

1.5

1.4

14.35

19.76

u/ml

0.68

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

101

10.87

92.97

1.5

1.3

61.00

72.22

titre

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

101

10.65

91.65

1.5

1.3

343.33

765.56

titre

—

(3021589) Normoblasts [#/volume] in Blood

1583

10429

2.17

86.94

10.9

8.5

0.00

e9/l

0.26

1361

8519

(3006504) Eosinophils/100 leukocytes in Blood

1610

10897

2.10

79.63

6.9

5.7

3.10

2.80

5.45

1535

10201

(3013650) Neutrophils [#/volume] in Blood by Automated count

1873

13424

2.16

79.58

8.9

8.6

3.98

3.97

e9/l

0.06

1690

11796

(3019069) Monocytes/100 leukocytes in Blood

1616

10971

2.10

79.04

7.1

6.0

8.00

8.22

2.52

1545

10299

(3022096) Basophils/100 leukocytes in Blood

1566

10519

2.09

78.70

6.9

5.8

0.68

0.26

1491

9809

(3002030) Lymphocytes/100 leukocytes in Blood

1647

11383

2.06

75.23

6.9

5.7

29.29

29.11

0.31

1580

10720

(40768443) Skin Pathology biopsy report

282

893

3.40

72.26

1.3

1.2

—

(3018010) Neutrophils/100 leukocytes in Blood

1612

11227

2.01

69.97

6.6

5.6

56.13

56.51

0.72

1540

10559

(40761536) Microorganisms panel - Urine sediment

473

2062

2.55

67.43

4.7

3.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2386

19438

2.43

65.83

5.2

4.1

14.56

14.52

pmol/l

0.39

2229

17982

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2172

17061

2.16

65.02

8.4

7.0

73.89

75.33

u/l

1.04

2067

16097

(3015171) Extractable nuclear Ab [Units/volume] in Serum

285

1013

3.02

59.87

1.3

3.17

0.96

u/ml

0.55

(3021601) Nitrite [Presence] in Urine by Test strip

1612

11596

1.90

59.50

5.5

4.6

0.00

estimate

0.36

463

2244

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1556

11097

1.89

58.65

5.8

9.81

10.44

umol/l

2.34

1460

10501

(3000850) Epithelial cells [#/volume] in Urine

768

4325

2.06

58.47

2.8

2.4

6.17

7.62

e6/l

2.13

692

3868

(3009261) Glucose [Presence] in Urine by Test strip

1618

11701

1.89

58.21

4.4

3.4

0.01

0.00

estimate

0.50

450

2189

(3035350) Ketones [Presence] in Urine by Test strip

1603

11577

1.88

57.71

4.5

3.4

0.00

estimate

0.20

470

2332

(3029937) Albumin [Presence] in Urine by Test strip

1000

6208

1.94

57.47

4.9

3.7

0.00

estimate

1.49

455

2212

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

979

6101

1.92

55.12

1.4

1.3

1.22

1.51

u/ml

0.49

309

1693

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1316

9052

1.85

54.07

4.4

3.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

11.95

53.27

1.1

0.99

7.03

u/ml

0.56

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2588

22454

2.73

52.57

6.1

4.8

1.78

2.09

mu/l

1.50

2434

21016

(3007164) IgA [Mass/volume] in Serum or Plasma

862

5217

1.94

52.49

1.7

1.4

2.21

2.22

g/l

0.09

575

3313

(3012494) Peanut IgE Ab [Units/volume] in Serum

8.04

51.61

1.1

0.38

2.03

u/ml

0.93

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

945

5960

1.88

50.30

2.4

2.1

125.58

178.50

u/l

3.12

880

5640

(3037467) Urinalysis macro (dipstick) panel - Urine

2024

16133

1.89

49.36

5.0

4.0

—

(36304419) Bacteria [Presence] in Urine

906

5673

1.88

49.09

3.2

2.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

101

198

5.25

48.97

1.3

1.2

2.04

1.36

u/ml

0.31

(3030467) Casts [#/volume] in Urine by Automated count

905

5713

1.86

47.48

3.2

2.9

0.24

0.36

e6/l

2.58

704

4278

(3018095) Leukocytes [#/volume] in Urine

1133

7674

1.79

47.03

3.8

3.4

70.33

90.42

e6/l

0.44

825

5172

(3044889) 12 lead EKG panel

1934

15314

1.83

46.74

4.0

3.2

—

(40768797) Stomach Pathology biopsy report

573

3121

2.05

46.45

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

967

6270

1.82

46.27

3.3

2.9

103.32

104.69

e6/l

0.01

759

4746

(3018418) pH of Serum or Plasma

935

6019

1.83

45.69

3.9

3.7

7.40

0.28

247

1135

(3015736) pH of Urine

1310

9334

1.75

45.03

3.8

3.1

5.77

5.93

0.84

110

898

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

723

4314

1.91

44.80

1.4

1.3

9.24

10.23

u/ml

0.17

318

1786

(3031040) Bacteria [#/volume] in Urine by Automated count

1932

15389

1.80

44.65

5.5

4.1

466.91

2082.85

e6/l

1.76

178

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1018

6775

1.78

44.16

2.7

2.5

54.79

58.06

u/l

1.76

937

6285

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

153

451

3.53

43.49

3.8

56.44

56.80

0.13

153

451

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

430

2178

2.15

41.93

1.3

1.2

145.37

158.91

iu/ml

0.20

161

838

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

183

623

3.07

41.16

1.2

1.1

1.98

2.83

u/ml

0.51

119

314

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2662

23931

2.81

40.92

16.3

11.6

15.97

20.87

mg/l

17.24

2209

18511

(3048689) Calprotectin [Mass/mass] in Stool

587

3356

1.94

40.90

2.8

2.3

91.51

106.57

ug/g

0.81

449

2644

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

9.56

40.69

1.0

1.1

0.71

11.20

u/ml

0.49

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

739

4561

1.84

40.57

1.4

1.3

32.04

27.35

iu/ml

0.43

258

1465

(3005719) IgG [Mass/volume] in Serum or Plasma

361

1730

2.25

40.34

2.9

2.6

10.19

10.50

g/l

0.77

327

1591

(3024561) Albumin [Mass/volume] in Serum or Plasma

1231

8808

1.70

40.21

4.7

4.5

36.71

36.29

g/l

2.08

1147

8208

(3041096) Erythrocytes [Presence] in Urine by Automated

974

6559

1.74

39.54

3.7

3.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1045

7207

1.71

38.71

2.9

3.2

2.35

mmol/l

0.07

944

6466

(3019550) Sodium [Moles/volume] in Serum or Plasma

2632

23634

2.57

38.67

15.6

12.4

139.53

139.64

mmol/l

1.93

2584

23013

(3023103) Potassium [Moles/volume] in Serum or Plasma

2636

23708

2.57

38.19

15.8

12.5

3.92

3.93

mmol/l

1.26

2586

23034

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1056

7324

1.70

38.18

3.6

3.0

20.61

37.90

ng/l

1.92

542

4127

(3036481) Cortisol [Moles/volume] in Serum or Plasma

426

2229

2.07

37.89

2.3

2.0

349.72

376.25

nmol/l

2.26

399

2050

(3026782) Osmolality of Urine

671

4095

1.84

37.83

2.9

2.7

513.02

532.81

mosm/kgh2o

1.47

575

3517

(3028026) IgM [Mass/volume] in Serum or Plasma

296

1340

2.35

37.72

2.1

1.8

1.32

1.41

g/l

0.36

274

1242

(3010726) Horse dander IgE Ab [Units/volume] in Serum

158

527

3.12

36.77

1.2

1.1

1.46

1.76

u/ml

0.24

104

251

(3003888) Timothy IgE Ab [Units/volume] in Serum

164

564

3.02

36.20

1.2

1.1

2.92

5.63

u/ml

2.19

294

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

395

2049

2.08

35.84

3.5

2.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

143

5.21

35.43

1.2

1.1

—

(3025159) Blasts/100 leukocytes in Blood

342

1695

2.16

34.92

3.4

4.3

0.13

0.50

0.64

410

(3002179) Metamyelocytes/100 leukocytes in Blood

343

1705

2.15

34.75

3.5

4.0

0.80

0.63

0.23

494

(3021440) Promyelocytes/100 leukocytes in Blood

353

1775

2.13

34.71

3.5

4.3

0.19

0.12

0.58

488

(3017181) Myelocytes/100 leukocytes in Blood

363

1858

2.09

34.04

3.5

4.2

1.14

0.92

0.40

572

(3007853) Bacteria identified in Skin by Aerobe culture

457

2560

1.94

33.20

1.8

1.6

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1300

9765

1.61

32.89

2.6

2.2

76.05

75.64

nmol/l

0.21

1186

8976

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

194

775

2.61

32.27

1.8

1.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1501

11723

1.60

31.85

3.4

2.8

95.37

89.14

ug/l

0.45

1390

11016

(44813793) Dust mix specific IgE antibody measurement

198

4.29

31.78

1.1

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

150

538

2.89

30.69

1.1

1.53

1.02

u/ml

0.22

222

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

322

1637

2.09

30.60

4.0

3.3

1.23

mmol/l

0.22

277

1411

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

584

3658

1.75

29.22

2.6

2.8

2.43

2.44

mmol/l

1.38

510

3201

(3013826) Glucose [Moles/volume] in Serum or Plasma

1563

12481

1.56

28.93

4.9

4.3

6.50

6.47

mmol/l

0.10

1468

11485

(3002385) Erythrocyte distribution width [Ratio]

2388

21157

1.81

28.86

17.7

13.9

14.15

14.72

1.82

2350

20773

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1207

9102

1.57

28.75

5.5

5.4

1.22

mmol/l

0.03

1125

8338

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

859

5992

1.62

28.44

1.9

1.6

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

10.10

28.28

1.0

0.03

0.06

u/ml

0.56

(3012095) Magnesium [Moles/volume] in Serum or Plasma

520

3188

1.77

27.90

3.2

3.4

0.83

0.82

mmol/l

0.70

488

3002

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

798

5497

1.63

27.67

2.3

2.1

2.76

2.81

mg/l

0.28

686

4714

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

665

4379

1.68

27.50

1.9

1.6

57989673.30

41092998.89

pmol/l

0.25

557

3716

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1309

10120

1.54

27.48

6.1

6.0

1.22

mmol/l

0.17

1057

8631

(3013139) Helicobacter pylori Ag [Presence] in Stool

309

1615

2.02

27.11

1.3

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

166

670

2.57

27.01

1.8

1.6

56.00

367.50

titre

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1147

8661

1.54

26.51

11.9

11.0

1.12

1.16

inr

1.16

515

2670

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2458

22107

1.84

26.39

13.6

10.4

89.29

87.59

ml/min/173m2

3.69

2097

18098

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

10.45

26.24

1.0

0.01

0.12

u/ml

0.58

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2712

25288

2.63

26.23

12.3

9.2

25.48

25.27

u/l

0.27

2640

24500

(3020874) Milk IgE Ab [Units/volume] in Serum

190

3.97

25.72

1.0

0.40

2.99

u/ml

0.78

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

169

712

2.46

25.11

1.2

33.72

40.03

u/ml

0.13

(3014133) Dog dander IgE Ab [Units/volume] in Serum

127

465

2.81

25.02

1.1

4.27

3.33

u/ml

0.34

214

(3020630) Protein [Mass/volume] in Serum or Plasma

271

1390

2.05

24.98

2.4

2.7

67.52

66.92

g/l

0.79

253

1286

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

763

5310

1.60

24.90

2.1

1.7

0.69

0.96

mg/l

5.45

539

3955

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2314

20558

1.68

24.69

5.6

4.8

38.47

38.48

mmol/mol

0.01

2178

19269

(3000492) Spirometry study

403

2371

1.82

24.61

1.6

1.4

—

(3026008) Bacteria identified in Urine by Culture

925

6767

1.54

24.11

3.1

2.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

323

3.14

23.94

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1033

7762

1.52

23.68

3.0

3.1

29.39

30.47

u/l

0.44

970

7392

(3022948) Iron [Moles/volume] in Serum or Plasma

506

3218

1.70

23.44

2.1

2.3

14.83

14.01

umol/l

1.42

462

3007

(3004789) Transferrin [Mass/volume] in Serum or Plasma

466

2898

1.73

23.43

2.1

2.3

2.49

2.41

g/l

2.45

417

2689

(3004588) Protein electrophoresis panel - Serum or Plasma

229

1138

2.10

22.94

2.2

2.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

126

481

2.69

22.93

1.2

1.08

3.50

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

152

640

2.45

22.61

1.2

4.96

7.48

u/ml

0.22

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

414

2516

1.76

22.52

2.4

2.7

5.54

6.95

umol/l

1.12

340

2156

(3022145) Colonoscopy Study observation

408

2471

1.76

22.46

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

153

650

2.43

22.32

1.2

1.3

2.99

9.06

u/ml

1.68

117

(3023430) Cat dander IgE Ab [Units/volume] in Serum

114

421

2.78

22.12

1.1

2.15

3.87

u/ml

1.27

161

(4200892) Spirometry reversibility

275

1483

1.95

21.92

1.6

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

261

1385

1.97

21.80

1.9

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

190

908

2.17

21.03

2.1

1.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1073

8274

1.48

21.00

1.9

1.8

97.82

97.58

pmol/l

0.06

576

4293

(3000494) Fungus identified in Specimen by Culture

426

2661

1.71

20.90

1.8

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1914

16520

1.49

20.74

3.4

2.9

45.20

39.99

u/l

1.72

1804

15625

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

8.74

20.66

1.0

0.01

u/ml

—

(40761511) CBC panel - Blood by Automated count

2688

25266

2.21

20.30

14.4

10.8

—

(3012501) Base excess in Blood by calculation

110

419

2.69

20.13

3.9

3.4

1.87

2.44

mmol/l

1.98

273

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

424

2673

1.69

20.05

2.2

2.3

24.19

23.77

0.24

371

2312

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2453

22437

1.69

19.83

4.5

3.9

5.77

5.74

mmol/l

0.57

2260

20774

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

655

4604

1.55

19.77

2.7

2.8

658.95

942.66

ng/l

2.77

540

3806

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

134

572

2.41

19.36

1.3

1.2

25.49

39.42

u/ml

0.63

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

195

976

2.07

19.14

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

732

5304

1.51

19.09

4.4

3.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

502

3342

1.61

19.08

1.8

1.7

1312.90

1188.79

nmol/l

2.29

388

2550

(3025941) Bacteria identified in Stool by Culture

267

1493

1.87

19.01

1.4

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

741

5396

1.51

18.83

2.6

2.3

1198.51

4166.65

umol/l

3.47

655

4815

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

194

979

2.05

18.62

1.6

2.0

42.81

38.89

u/l

1.83

183

894

(1616796) Gas panel - Central venous blood

104

401

2.65

18.60

3.6

3.1

—

(4062490) Immunoglobulin typing, IgG

237

3.18

18.51

1.9

1.4

—

(40758558) Short blood count panel - Blood

791

5854

1.49

18.51

6.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

352

2.76

18.36

1.5

1.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

116

475

2.50

18.35

1.1

1.2

—

9.13

—

(40767503) Oxygen content in Capillary blood by calculation

375

2.70

18.33

3.0

2.4

16.98

16.43

0.67

184

(3039162) Centromere protein B Ab [Units/volume] in Serum

310

2.86

18.09

1.2

1.3

32.40

46.42

u/ml

—

(40768804) Tissue Pathology biopsy report

1209

9767

1.41

17.43

2.2

2.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

191

3.35

17.24

1.0

0.49

0.98

u/ml

0.54

(3024139) IgG subclass 3 [Mass/volume] in Serum

232

3.11

17.20

1.8

1.4

0.36

0.38

g/l

0.21

159

(3028192) IgG subclass 2 [Mass/volume] in Serum

232

3.11

17.20

1.8

1.4

2.82

2.95

g/l

0.28

159

(3027135) IgG subclass 1 [Mass/volume] in Serum

233

3.10

17.07

1.8

1.4

6.12

6.67

g/l

0.82

161

(3015076) Soybean IgE Ab [Units/volume] in Serum

175

3.42

16.71

1.1

1.0

0.22

2.31

u/ml

0.53

(3007461) Platelets [#/volume] in Blood

2795

26958

3.43

16.16

23.5

17.2

265.44

261.47

e9/l

2.69

2755

26368

(3009542) Hematocrit [Volume Fraction] of Blood

2792

26925

3.28

15.90

23.5

17.2

40.38

40.05

2.74

2684

25548

(3026361) Erythrocytes [#/volume] in Blood

2795

26982

3.37

15.65

23.5

17.1

4.52

4.49

e12/l

2.29

2748

26346

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

383

2.53

15.56

1.1

0.04

0.26

u/ml

1.72

104

(3010421) pH of Blood

115

507

2.32

15.49

3.9

3.4

7.42

0.35

110

451

(3035941) MCH [Entitic mass]

2794

26976

3.30

15.46

23.4

17.1

30.14

30.11

0.34

2771

26670

(3024731) MCV [Entitic volume]

2794

26977

3.30

15.44

23.4

17.1

90.44

90.42

0.09

2771

26673

(3010813) Leukocytes [#/volume] in Blood

2794

26978

3.30

15.42

23.5

17.2

6.80

6.66

e9/l

2.03

2749

26335

(3024980) IgG subclass 4 [Mass/volume] in Serum

379

2.53

15.40

1.9

1.6

0.71

0.74

g/l

0.11

285

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

6.46

15.37

1.0

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

14.82

15.34

1.1

1.0

0.20

0.97

u/ml

—

(3000963) Hemoglobin [Mass/volume] in Blood

2794

26991

3.27

15.15

23.7

17.2

135.58

134.62

g/l

3.99

2772

26681

(3034274) Bile acid [Moles/volume] in Serum --fasting

116

522

2.27

14.91

1.9

2.2

4.75

4.76

umol/l

0.01

379

(3017143) Hepatitis C virus Ab [Presence] in Serum

484

3366

1.53

14.88

1.6

—

(3013512) EKG study

743

5638

1.43

14.66

3.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

14.23

14.52

1.0

0.42

0.22

u/ml

0.23

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

260

1589

1.70

13.61

1.4

1.3

15.58

42.76

au/ml

—

(3021960) Folate [Moles/volume] in Serum or Plasma

607

4497

1.44

13.48

1.6

1.5

19.27

20.89

nmol/l

2.06

522

3914

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

479

3395

1.49

13.34

2.7

2.5

1.15

1.28

e6/l

0.23

256

1874

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

9.36

12.95

1.0

0.01

1.15

u/ml

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

278

1758

1.64

12.76

3.4

3.3

4.44

4.54

pmol/l

0.85

254

1565

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

276

1748

1.64

12.59

2.7

2.2

3779.26

5428.83

u/l

0.52

101

695

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

229

1383

1.71

12.51

2.3

2.2

2.96

6.80

ug/l

11.55

197

1237

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

274

1735

1.64

12.51

2.5

2.3

11.32

22.97

au/ml

2.77

164

(36660697) Celiac disease serology panel - Serum

323

2132

1.58

12.43

1.2

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

10.53

12.24

1.0

0.03

4.33

u/ml

0.50

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

193

1120

1.78

12.14

7.4

7.2

24.64

24.83

mmol/l

0.30

188

1113

(3048929) Epstein Barr virus Ab [Presence] in Serum

169

942

1.84

12.13

1.4

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

125

635

2.01

11.84

1.3

1.2

77.37

85.10

titre

0.15

(3003458) Phosphate [Moles/volume] in Serum or Plasma

361

2472

1.53

11.77

5.0

5.4

1.02

1.04

mmol/l

1.04

340

2309

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

122

618

2.02

11.65

1.6

2.1

8.63

11.55

mg/l

3.44

117

578

(3000570) Elastase.pancreatic [Mass/mass] in Stool

117

585

2.04

11.58

1.3

1.4

341.28

299.13

ug/g

1.22

311

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

136

718

1.94

11.54

1.2

1.1

—

(3042936) Bacteria identified in Isolate by Culture

418

2967

1.48

11.44

1.9

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2494

23484

1.51

11.43

4.8

4.2

2.86

mmol/l

0.14

2314

22040

(3019150) Specific gravity of Urine by Refractometry

654

5042

1.39

11.33

4.9

3.7

1.02

kg/l

0.29

727

(3023368) Bacteria identified in Blood by Culture

641

4926

1.39

11.32

4.7

4.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

404

2.24

11.28

2.5

2.3

131.23

130.15

g/l

0.16

308

(3052851) Hemolysis interference index of Serum or Plasma

123

634

1.98

11.19

2.8

2.9

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

135

721

1.92

11.08

1.2

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

426

3054

1.46

11.06

2.2

1.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

545

4093

1.41

10.98

2.4

2.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

196

2.79

10.97

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

196

2.79

10.97

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

196

2.79

10.97

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

196

2.79

10.97

1.2

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

142

774

1.88

10.96

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

197

2.77

10.87

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

197

2.77

10.87

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

4.21

10.81

2.0

2.1

227.78

148.42

e6/l

0.98

(42529406) Shigella sp [Presence] in Stool by Culture

135

728

1.90

10.77

1.2

—

(3021901) Oxygen saturation in Capillary blood

293

2.42

10.69

2.9

2.7

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

7.99

10.58

1.0

0.06

0.57

u/ml

0.48

(46235355) HIV 1 and 2 tests - Meaningful Use set

789

6327

1.34

10.52

2.1

1.9

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.36

10.51

3.7

3.8

—

(40761535) Cells panel - Urine sediment

254

1648

1.59

10.48

4.1

3.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.42

10.26

1.3

1.1

90.84

98.77

0.75

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2013

18383

1.33

10.24

4.2

3.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

350

2450

1.49

10.22

7.7

5.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

585

1.97

10.18

1.9

2.4

10.13

10.28

g/l

0.13

107

539

(3023323) Follitropin [Units/volume] in Serum or Plasma

275

1831

1.56

10.15

1.4

1.3

23.13

26.87

iu/l

1.25

227

1563

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2460

23209

1.45

10.06

4.4

3.9

4.77

4.79

mmol/l

0.47

2304

21900

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

145

3.00

10.00

2.7

2.4

0.25

0.21

e9/l

0.59

124

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

490

2.04

9.75

1.6

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

149

2.91

9.55

2.8

2.4

589.09

555.22

e6/l

0.15

123

(3011985) Renin [Units/volume] in Plasma

278

2.37

9.51

1.6

35.78

48.43

mu/l

0.53

256

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

589

4581

1.36

9.46

2.6

2.1

—

(3033658) Prothrombin time (PT) actual/Normal

688

5485

1.34

9.37

3.9

3.6

96.42

95.12

0.76

660

5320

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

118

643

1.87

9.16

1.9

2.3

7.07

7.38

g/l

1.51

112

598

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

118

643

1.87

9.16

1.9

2.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

265

2.37

9.09

2.0

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

758

6150

1.32

9.09

3.4

3.2

7.99

7.49

mmol/l

1.93

636

5313

(3012516) Albumin [Mass/volume] in Urine

666

5318

1.33

8.91

3.4

3.3

554.53

365.32

mg/l

0.37

408

3320

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

113

613

1.88

8.90

1.8

2.3

2.83

2.95

g/l

0.98

107

568

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

722

5834

1.32

8.88

1.6

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

256

1728

1.53

8.88

2.0

2.4

73.53

72.31

ml/min/173m2

0.17

652

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

117

643

1.85

8.86

1.9

2.3

3.82

3.58

g/l

1.45

111

598

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

405

2.08

8.85

3.2

2.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

501

1.97

8.84

1.8

2.3

0.01

g/l

0.04

474

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

439

2.04

8.84

1.1

13.29

13.21

au/ml

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

6.82

8.83

1.0

0.01

1.08

u/ml

0.81

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

460

2.01

8.82

1.8

2.4

0.00

g/l

-0.00

435

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

257

2.36

8.77

1.4

2007.09

339.23

pmol/l

0.49

234

(3018001) Oat IgE Ab [Units/volume] in Serum

9.49

8.76

1.1

1.0

0.33

0.21

u/ml

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

103

545

1.92

8.76

1.4

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

140

2.88

8.75

1.8

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

462

2.00

8.72

1.8

2.4

0.00

g/l

-0.00

436

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

7.64

8.63

1.0

3.36

3.95

u/ml

0.13

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2438

23094

1.40

8.54

4.3

3.8

1.48

1.51

mmol/l

3.11

2260

21707

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

194

2.55

8.48

1.0

1.1

—

33.84

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

200

2.53

8.48

2.1

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

230

1532

1.55

8.48

6.3

7.3

7.72

8.33

mmol/l

0.77

221

1463

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

509

1.94

8.46

1.8

2.3

39.22

38.18

g/l

0.94

464

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

104

559

1.89

8.45

1.6

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

399

2963

1.40

8.43

1.9

2.1

29.82

29.45

0.60

386

2863

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

291

2039

1.48

8.42

4.3

4.2

229.15

242.18

u/l

0.69

266

1930

(1761868) Lipid panel - Serum or Plasma

1083

9291

1.27

8.25

2.9

2.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

320

2297

1.44

8.17

1.9

1.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

718

5855

1.30

8.16

1.7

1.6

1.41

1.36

mmol/l

0.69

561

5027

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

454

1.97

8.08

1.6

1.4

150.65

107.80

u/ml

0.36

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

127

737

1.76

8.06

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

227

1525

1.53

8.05

1.1

1.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

468

3595

1.36

8.03

3.7

3.2

209.54

356.15

ng/l

0.68

273

2358

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

10.05

8.02

1.1

0.02

0.13

u/ml

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

132

776

1.74

8.01

1.1

8.78

3.86

u/ml

0.55

113

(3004616) Nuclear Ab [Presence] in Serum

262

2.28

7.98

1.1

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

200

1309

1.57

7.97

1.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

301

2.19

7.95

1.2

1.3

0.52

0.58

nmol/l

0.91

290

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

3.21

7.93

1.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

341

2.11

7.92

2.2

1.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2355

22243

1.35

7.92

3.9

3.5

1.30

1.25

mmol/l

3.35

2176

20802

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

121

2.92

7.85

1.8

2.6

925.77

918.13

u/ml

0.01

121

(3038177) Helicobacter pylori Ab [Presence] in Serum

453

1.95

7.79

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

269

1887

1.47

7.74

2.1

2.2

0.23

0.22

g/l

1.48

249

1774

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

101

555

1.85

7.69

1.9

2.5

0.30

0.87

g/l

1.75

503

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

418

3189

1.36

7.46

2.9

2.7

3.42

3.53

e6/l

0.07

193

1674

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

103

3.03

7.46

1.1

1.0

3.75

15.41

u/ml

4.22

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

518

1.86

7.42

1.4

1.2

277.95

265.75

u/ml

0.16

323

(3004716) Salmonella sp identified in Stool by Organism specific culture

232

1598

1.49

7.32

1.5

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

186

2.44

7.17

1.6

1.4

34.51

35.59

0.06

110

(3008898) HLA-B27 [Presence]

172

1116

1.58

7.14

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

384

2914

1.37

7.08

2.1

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

290

2104

1.42

6.98

2.1

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

286

2070

1.42

6.97

2.0

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

677

5576

1.28

6.97

4.1

3.8

8.12

9.03

mg/mmol

0.19

408

3488

(3011412) CD3 cells [#/volume] in Blood

215

2.30

6.86

2.8

2.4

1.60

1.27

e9/l

1.63

194

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

280

2.13

6.84

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

407

3138

1.35

6.76

1.7

1.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

169

2503

0.65

6.62

4.0

3.9

30.74

32.33

1.40

129

1796

(3027945) Reticulocytes/100 erythrocytes in Blood

272

1973

1.42

6.55

2.9

2.8

1.86

1.78

0.48

239

1752

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1245

11051

1.23

6.48

2.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

126

779

1.65

6.41

1.7

1.6

0.64

0.33

iu/ml

0.21

152

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

184

2.36

6.39

1.1

6.52

10.22

iu/ml

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

284

2089

1.40

6.32

2.5

2.3

31.05

59.22

u/l

0.66

232

1784

(3035637) Corticotropin [Mass/volume] in Plasma

269

2.10

6.32

1.7

1.5

—

(1002224) Polysomnography panel

167

1108

1.54

6.31

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.26

6.27

1.7

1.5

9.06

8.45

ug/l

0.46

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

103

2.83

6.26

1.7

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.01

6.22

1.7

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

162

2.43

6.19

1.1

0.14

5.85

nmol/l

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

190

1302

1.49

6.18

1.8

1.6

276.61

298.20

mu/l

0.66

167

1160

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

342

1.95

6.07

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

154

1013

1.55

6.06

2.3

2.2

—

(3016502) Oxygen saturation in Arterial blood

238

1710

1.43

6.06

6.3

8.3

96.41

95.94

0.76

226

1653

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

170

2.37

6.05

2.0

2.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

8.60

6.05

1.1

0.01

0.07

u/ml

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

158

2.42

6.03

1.1

1.2

—

44.88

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

268

2.07

6.00

1.3

—

nmol/l

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

227

1622

1.43

5.96

5.9

8.6

124.42

121.66

g/l

1.22

217

1578

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

551

1.73

5.85

1.3

1.4

2.85

22.80

e6/l

3.82

424

(3002256) Pathology report gross observation

381

2975

1.32

5.78

1.3

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.08

5.76

1.8

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

160

1075

1.52

5.73

2.5

2.0

11.56

11.19

nmol/l

0.21

139

969

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.92

5.71

1.4

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

630

5259

1.25

5.66

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

550

1.71

5.63

1.4

1.5

408.79

1621.24

e6/l

1.23

448

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

183

1270

1.47

5.61

2.9

2.7

128.28

159.81

ng/l

0.65

162

1133

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

410

1.83

5.59

6.5

5.6

439.00

251.73

iu/ml

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.52

5.55

1.2

1.1

—

(3021788) Differential panel - Synovial fluid

382

1.85

5.55

1.8

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.86

5.52

1.1

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

441

1.79

5.52

1.1

4.71

2.37

u/ml

0.44

228

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

172

2.29

5.46

1.2

1.3

290.00

192.89

titre

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.08

5.43

1.2

1.1

—

(3023419) Bacteria identified in Sputum by Culture

266

2.01

5.38

5.1

2.7

—

(3029075) Extractable nuclear Ab panel - Serum

3.03

5.37

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

475

1.75

5.35

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.93

5.30

2.1

10.10

9.80

mg/l

0.08

(3002523) Influenza virus A Ag [Presence] in Specimen

477

1.74

5.28

1.1

—

(3042631) Mycobacterium sp identified in Specimen

214

2.12

5.27

3.1

2.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

102

2.66

5.24

1.7

1.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

102

2.66

5.24

1.4

1.3

14.00

4.23

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

262

2.00

5.23

1.9

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

262

2.00

5.23

1.2

—

(3020891) Body temperature

109

686

1.61

5.22

3.5

4.8

—

(3019060) Gas panel - Arterial blood

157

1074

1.49

5.19

3.6

5.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

217

2.09

5.09

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

166

2.25

5.01

1.1

1.09

1.10

u/l

0.01

(3000012) Reticulocyte production index

219

2.07

4.98

2.5

2.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

135

2.39

4.97

1.2

1.5

5.09

6.04

u/l

0.51

114

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

412

1.77

4.93

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.49

4.89

1.1

0.54

0.71

umol/24h

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

534

1.67

4.89

1.6

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

195

1407

1.41

4.89

2.9

2.7

75.76

72.12

e9/l

0.53

143

1045

(3049717) Cytology report of Urine Cyto stain

550

1.66

4.87

1.9

2.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

474

1.71

4.86

2.2

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

208

2.08

4.84

3.2

7.2

7.56

6.88

mmol/l

0.59

174

(3045414) Leukocytes [Presence] in Urine

152

1055

1.47

4.70

2.0

1.8

—

(3003396) Base excess in Arterial blood by calculation

258

1963

1.35

4.68

6.2

7.7

1.36

1.01

mmol/l

0.81

198

1548

(3014111) Lactate [Moles/volume] in Serum or Plasma

214

1581

1.38

4.68

7.4

7.1

1.22

1.32

mmol/l

1.05

209

1543

(3024891) Influenza virus A+B Ag [Presence] in Specimen

105

674

1.58

4.67

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

581

1.62

4.63

1.4

0.38

0.45

nmol/l

0.24

470

(3002079) Sodium [Moles/time] in 24 hour Urine

109

2.49

4.62

1.2

1.5

125.48

155.40

mmol/24h

1.67

109

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

347

1.80

4.59

1.9

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

104

2.51

4.54

3.1

3.0

8.10

7.63

mg/l

0.16

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

423

1.72

4.53

1.3

1.2

5.72

4.10

u/ml

0.14

125

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

257

1.92

4.45

1.6

1.4

—

(40768793) Breast Pathology biopsy report

635

1.58

4.44

1.4

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

5.81

4.44

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

136

940

1.47

4.32

1.4

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

553

1.61

4.30

1.2

1.3

3.63

3.67

mmol/l

0.15

522

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

477

1.65

4.25

2.3

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

255

1966

1.33

4.25

6.3

7.7

4.95

5.07

kpa

1.34

240

1878

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

192

2.05

4.24

1.6

1.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

254

1966

1.32

4.12

6.2

7.7

12.41

12.92

kpa

0.80

239

1883

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.99

4.12

1.1

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

236

1.92

4.11

1.0

1.2

29.86

35.95

mg/l

0.83

195

(3008152) Bicarbonate [Moles/volume] in Arterial blood

148

1052

1.43

4.08

5.5

7.3

24.32

24.42

mmol/l

0.12

137

999

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

522

1.61

4.07

2.5

2.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

175

2.07

4.05

1.2

—

(40768795) Lymph node Pathology biopsy report

210

1.97

4.01

1.1

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

6.44

3.98

1.0

1.1

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.57

3.97

1.5

1.7

1.35

1.24

mg/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

211

1.96

3.96

1.3

—

titre

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

118

2.30

3.94

1.7

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

106

2.37

3.90

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

412

1.67

3.87

1.3

4.70

4.60

u/ml

0.01

166

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

227

1.91

3.87

1.0

1.1

199.64

226.39

mg/l

0.66

196

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

263

1.84

3.86

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

406

1.67

3.82

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

8.77

3.77

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

439

1.63

3.75

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.65

3.73

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

496

1.59

3.68

1.3

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

217

1.90

3.68

2.5

2.2

31.37

32.24

0.46

217

(3010838) Calcium [Moles/time] in 24 hour Urine

412

1.64

3.63

2.1

1.9

4.80

5.27

mmol/24h

0.57

369

(3000991) Gas panel - Venous blood

198

1509

1.34

3.61

7.6

8.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

467

3951

1.22

3.60

1.8

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

205

1.92

3.58

1.3

1.1

63.76

63.71

u/l

0.00

190

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

256

1.81

3.55

1.7

1.6

66.23

58.86

0.56

161

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

377

3135

1.23

3.44

4.8

4.5

1.75

2.27

ug/l

2.17

339

2814

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

274

1.76

3.42

2.4

2.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

126

2.15

3.41

1.6

1.5

4.59

5.63

u/l

0.16

108

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

216

1.86

3.40

1.0

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

275

2209

1.27

3.40

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

389

1.63

3.38

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

389

1.63

3.38

1.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.58

3.38

1.3

5.1

58.64

59.02

mg/l

0.01

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

101

694

1.47

3.38

1.7

2.0

3.68

4.38

iu/l

0.46

265

(4035726) Immunohistochemistry procedure

237

1871

1.29

3.36

1.5

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

168

1.98

3.34

1.7

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

182

1.93

3.33

1.2

1.1

1.05

1.04

ratio

0.51

(3037756) Immunofixation for Serum or Plasma

337

1.68

3.32

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

478

1.56

3.31

1.8

1.7

14490.24

11599.70

e6/l

0.23

346

(3009343) pH of Capillary blood

149

1103

1.37

3.30

3.2

3.1

7.42

7.41

0.30

147

(3000093) Morphology [Interpretation] in Blood Narrative

155

2.01

3.29

1.2

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

206

1604

1.31

3.25

5.0

3.6

5.80

5.84

kpa

0.22

201

1550

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

170

1.95

3.24

1.7

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

150

1116

1.36

3.23

3.2

3.1

5.13

5.14

kpa

0.09

142

1068

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

103

2.24

3.22

1.2

1.1

—

(3051651) Icteric interference index of Serum or Plasma

136

2.07

3.22

2.5

3.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

306

2507

1.25

3.21

4.6

3.9

22.20

20.94

0.58

135

1082

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

305

1.68

3.11

1.6

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

152

1.98

3.09

3.0

2.6

911.90

693.95

e6/l

1.24

147

(3024263) Appearance of Synovial fluid

2.27

3.03

1.1

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

157

1190

1.34

3.01

2.1

1.8

—

(3002032) Base excess in Venous blood by calculation

203

1596

1.29

3.00

5.0

3.6

2.06

1.86

mmol/l

0.34

173

1337

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

143

1070

1.35

2.99

3.2

3.1

2.09

1.62

mmol/l

0.87

100

785

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

10.01

2.98

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

219

1.79

2.97

1.1

—

(3017732) Neutrophils [#/volume] in Blood

212

1680

1.28

2.95

2.3

2.6

4.00

5.18

e9/l

1.91

183

1437

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

501

1.51

2.92

1.4

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

155

1179

1.33

2.91

1.4

1.3

270.80

223.93

miu/ml

0.72

607

(40760888) Immunoglobulin light chains.free panel - Serum

366

1.60

2.90

4.6

3.8

—

(3016750) Collection duration of Urine

115

2.10

2.88

1.9

2.4

475.46

497.66

min

0.39

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

370

3131

1.21

2.86

1.6

1.8

1.40

1.39

0.16

310

2809

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

190

1492

1.29

2.85

3.5

92.83

78.00

ng/l

0.59

168

1311

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

433

1.54

2.80

2.7

2.5

139.13

100.65

ug/min

0.14

268

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

613

1.45

2.80

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

680

1.43

2.80

2.2

2.7

3.63

3.56

g/l

0.16

640

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

166

1287

1.31

2.75

1.6

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

113

1524

0.73

2.74

1.5

1.4

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

5.01

2.73

1.4

2.4

4.00

3.00

mg/l

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

5.01

2.73

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

412

1.54

2.72

1.1

122.02

118.17

0.47

375

(3028433) Virus identified in Specimen by Culture

2.37

2.72

1.2

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.15

2.70

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

197

1.79

2.67

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

212

1.76

2.67

2.8

2.9

—

(4146454) Self-monitoring of blood glucose

185

0.32

2.66

2.0

2.7

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.80

2.64

1.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.80

2.64

1.2

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.80

2.64

1.2

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.22

2.63

1.0

1.3

97.67

96.82

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.55

2.61

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

184

1.80

2.61

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.68

2.59

2.6

1.3

44.43

50.00

umol/l

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

566

1.44

2.56

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

114

2.03

2.56

1.4

1.1

13.53

21.89

u/l

0.55

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

142

1.91

2.55

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.14

2.54

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

405

1.52

2.49

1.1

111.92

1338.85

iu/ml

0.49

100

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

263

1.64

2.48

4.0

4.7

30.84

91.75

u/ml

1.30

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

180

1.79

2.47

1.3

1.4

1.71

1.91

mmol/l

1.60

169

(3009871) Measles virus Ab [Titer] in Serum

2.20

2.47

1.9

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

522

1.45

2.44

1.2

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

3.13

2.43

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

138

1.89

2.41

1.0

1.1

99.50

90.29

0.67

111

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.01

2.40

1.2

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.01

2.40

1.2

1.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

466

1.47

2.40

3.9

3.6

1.16

1.66

ratio

—

(3024869) Neuronal Ab [Presence] in Serum

3.34

2.39

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

6.26

2.37

1.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

703

1.38

2.36

2.3

2.6

165.96

173.22

0.36

672

(3009214) Lutropin [Units/volume] in Serum or Plasma

111

833

1.35

2.34

1.6

1.3

11.62

10.66

u/l

0.26

684

(3003181) Sodium [Moles/volume] in Urine

307

1.57

2.33

1.2

1.4

61.11

63.45

mmol/l

0.16

257

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.31

1.2

1.0

—

(3044941) Cell count panel - Synovial fluid

325

1.55

2.27

1.7

1.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

169

0.35

2.27

4.3

12.9

583.83

850.25

nmol/l

—

162

(3034860) Kappa light chains.free [Mass/volume] in Serum

480

1.45

2.27

4.6

3.6

42.47

68.19

mg/l

0.92

393

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.07

2.27

1.0

1.1

104.00

94.33

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

472

1.45

2.26

1.5

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

481

1.45

2.25

4.6

3.7

32.53

51.14

mg/l

0.75

394

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

543

0.60

2.24

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

424

1.47

2.23

1.2

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.86

2.20

1.1

1.3

—

(3036489) Thrombin time

118

903

1.32

2.20

2.0

2.1

20.56

20.94

0.55

767

(3019977) pH of Arterial blood

2.08

2.17

1.9

3.2

7.41

7.42

—

(3006653) Thiamine [Moles/volume] in Blood

122

1.89

2.16

1.2

1.5

145.74

131.00

nmol/l

0.83

122

(21494890) Protein electrophoresis panel - 24 hour Urine

166

1.75

2.15

1.9

—

(3001729) Color of Synovial fluid

4.29

2.15

1.2

1.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

596

1.39

2.14

2.1

2.4

271.42

286.87

ug/l

0.06

548

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

224

2679

0.82

2.12

1.5

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

347

1.51

2.12

1.4

1.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.05

2.11

1.4

94.78

77.87

nmol/24h

0.50

(3016244) Insulin [Units/volume] in Serum or Plasma

198

1.67

2.08

2.7

3.3

19.22

24.91

mu/l

0.73

189

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

599

1.38

2.08

1.8

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.71

2.07

1.2

—

(3004775) Volume in Urine collected for unspecified duration

147

1.78

2.02

2.0

2.3

741.60

624.66

0.63

101

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.23

2.01

2.6

1.2

—

(3034426) Prothrombin time (PT)

2.01

2.00

1.2

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

787

7236

1.12

2.00

2.3

2.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.97

2.00

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

248

1.58

1.98

1.2

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

329

1.50

1.96

1.4

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

117

911

1.30

1.96

8.9

9.9

24.72

24.30

mmol/l

0.70

112

890

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

641

1.35

1.95

2.0

3.51

1.70

ug/l

0.32

576

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.55

1.94

1.2

2.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

187

1.67

1.94

1.2

1.3

4.27

5.18

umol/l

0.76

176

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.76

1.93

1.2

1.7

—

(3002619) Bacteria identified in Specimen by Culture

2.45

1.93

1.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.45

1.93

1.5

1.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

739

1.32

1.91

2.0

1.9

1.44

1.49

g/l

0.20

642

(3036071) Salmonella sp Ab [Titer] in Serum

1.93

1.90

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

101

775

1.31

1.89

2.1

2.3

97.45

93.80

1.21

741

(3011648) Oxygen content in Venous blood

143

1.75

1.89

12.1

2.8

12.31

11.03

0.88

143

(3022621) pH of Urine by Test strip

181

1495

1.23

1.85

3.0

2.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

389

3436

1.15

1.84

1.6

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

401

1.43

1.83

1.1

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

4.17

1.82

1.0

—

(3035320) C reactive protein [Mass/volume] in Body fluid

169

1.66

1.77

2.3

2.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

102

1.87

1.76

1.1

1.4

194.28

156.64

pmol/l

0.69

102

(40757373) Influenza virus identified in Isolate

2.67

1.72

3.8

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

424

1.40

1.70

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

141

1.71

1.68

1.2

1.1

1529.67

1549.21

miu/ml

0.03

141

(3009015) Lactate [Moles/volume] in Synovial fluid

3.16

1.66

1.0

1.4

5.22

5.85

mmol/l

—

(3050794) Legionella sp Ab [Presence] in Serum

3.16

1.66

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

555

1.34

1.65

7.6

3.8

1.40

1.41

mg/l

0.02

522

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

236

1.53

1.65

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

228

1.54

1.65

1.3

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

189

1.59

1.63

1.1

1.0

278.87

296.58

mg/l

0.73

170

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.58

1.61

1.2

1.8

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.58

1.61

1.0

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

143

1.68

1.61

2.5

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

128

1.72

1.60

2.1

2.8

47.47

44.41

0.53

(3024928) Oxygen saturation in Venous blood

379

1.41

1.59

8.1

2.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

106

1.80

1.58

2.4

2.1

66.71

180.85

umol/l

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

388

1.40

1.58

1.5

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.85

1.56

1.6

2.2

115.53

133.47

0.74

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

264

1.48

1.56

1.7

1.4

—

(3004451) EKG impression Narrative

1.98

1.53

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

348

1.42

1.53

1.9

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

266

1.47

1.51

1.7

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.86

1.50

2.3

2.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

235

1.50

1.46

1.9

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

163

1.60

1.46

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

211

1.52

1.46

1.9

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

107

1319

0.80

1.43

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

270

1.45

1.42

1.7

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.25

1.40

1.7

2.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

110

893

1.24

1.39

7.7

10.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

263

1.45

1.39

1.7

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

424

1.35

1.39

1.1

—

(3045142) Bone marrow Pathology biopsy report

214

1.50

1.38

1.3

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

112

913

1.24

1.37

1.5

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

547

1.31

1.37

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

104

1.74

1.37

1.3

2.8

—

29.84

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

289

1.42

1.36

1.3

1.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.94

1.36

1.0

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

265

1.44

1.34

1.7

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

139

1162

1.21

1.33

1.7

1.5

—

(21494755) Public health laboratory ask at order entry panel

270

3048

0.87

1.33

1.4

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

410

1.35

1.33

1.1

—

(3008295) Osmolality of Serum or Plasma

208

1.50

1.32

1.3

1.5

279.73

279.09

mosm/kgh2o

0.06

159

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1207

0.81

1.32

1.4

—

(40768806) Pleura Pathology biopsy report

146

0.48

1.32

1.4

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1206

0.81

1.31

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1206

0.81

1.31

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

1.69

1.31

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

152

1.58

1.31

1.1

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

201

1.50

1.29

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1201

0.81

1.27

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.79

1.27

2.4

3.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

213

1858

1.16

1.26

1.8

1.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

154

1.56

1.25

1.1

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

432

1.33

1.25

1.5

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.74

1.25

1.0

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.00

1.23

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

790

1.24

1.22

2.1

1.9

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

263

1.41

1.20

1.7

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

165

1.52

1.17

1.5

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

157

1.53

1.17

5.4

7.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

149

1.55

1.17

1.2

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1034

0.81

1.16

1.6

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.50

1.15

1.0

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.85

1.13

1.1

1.4

97.00

119.87

nmol/l

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.34

1.12

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.90

1.12

3.2

2.2

12.21

16.49

umol/l

0.94

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.96

1.11

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

160

1.50

1.09

1.5

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

2.38

1.09

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

1.82

1.09

1.1

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

210

1.43

1.08

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.19

1.08

1.1

2.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1001

0.81

1.07

1.5

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

153

1.51

1.06

1.2

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.93

1.06

1.9

2.8

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.93

1.06

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.93

1.06

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.93

1.06

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.93

1.06

1.0

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.93

1.06

1.9

2.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.12

1.05

6.6

6.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.12

1.05

1.0

—

(3005033) Fetal Nuchal fold Thickness US

999

0.82

1.05

1.5

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

179

1.46

1.03

2.1

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

179

1.46

1.03

2.1

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

179

1.46

1.03

2.1

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

600

1.24

1.01

2.5

2.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.89

1.01

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.89

1.01

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

1.65

1.00

42.6

32.4

7.39

7.34

ug/l

0.04

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.88

1.00

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

206

2316

0.88

1.00

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

2.18

0.98

2.0

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.74

0.96

3.5

2.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

705

1.21

0.95

1.9

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.69

0.95

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

163

1853

0.87

0.95

1.3

1.4

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

373

1.29

0.94

1.8

—

3.71

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

185

0.59

0.94

1.5

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

200

1.40

0.93

3.1

3.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

204

1822

1.13

0.91

2.9

2.8

0.83

0.73

ug/l

0.28

132

1125

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.07

0.89

1.0

1.2

1.83

1.67

umol/24h

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

152

1.45

0.88

1.2

1.3

66.09

73.95

umol/l

1.54

152

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.79

0.87

1.0

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.61

0.87

1.3

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.86

0.87

1.9

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

596

1.21

0.85

1.8

2.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.74

0.82

1.4

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.70

0.82

3.0

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.88

0.81

4.7

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

198

1.37

0.80

1.3

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.79

0.0

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

139

1.44

0.79

1.3

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

339

1.27

0.79

2.4

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

339

1.27

0.79

2.4

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

556

1.21

0.78

1.6

1.4

19.21

24.55

u/l

0.76

479

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.78

0.0

2.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.51

0.78

2.0

2.4

155.00

145.17

nmol/l

—

(3042517) Benzodiazepines panel - Urine

1.77

0.76

4.3

2.4

—

(3027944) Amphetamines [Presence] in Urine

152

1352

1.13

0.76

1.9

2.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.70

0.75

5.5

2.9

—

(3000764) Benzodiazepines [Presence] in Urine

153

1363

1.13

0.75

2.0

2.1

—

(40768441) Liver Pathology biopsy report

175

1.37

0.74

1.3

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.09

0.74

1.0

—

(3028300) Cannabinoids [Presence] in Urine

154

1375

1.13

0.73

2.1

—

(3025130) Human papilloma virus identified in Specimen

515

1.21

0.73

2.0

1.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.00

0.72

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.00

0.72

1.6

1.3

61.68

106.81

ng/l

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.61

0.72

1.1

—

(3023410) Appearance of Cerebral spinal fluid

255

1.30

0.71

1.3

1.7

—

(3027008) Opiates [Presence] in Urine

153

1371

1.12

0.69

1.9

2.1

—

(3011288) Drugs identified in Urine by Screen method

109

956

1.15

0.69

2.1

2.8

—

(40768446) Kidney Pathology biopsy report

1.53

0.69

1.7

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

1.64

0.68

13.0

9.6

—

(3045424) Erythrocytes [Presence] in Urine

383

1.23

0.68

1.2

1.5

—

(3047181) Lactate [Moles/volume] in Blood

557

1.19

0.67

3.8

6.6

1.32

1.23

mmol/l

0.49

484

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

136

1.40

0.66

1.4

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

448

1.21

0.66

5.3

3.5

20.12

21.61

mg/l

0.16

280

(1617658) Protocol used for examination of sentinel lymph nodes

224

0.71

0.64

1.0

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.73

0.64

1.0

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.50

0.63

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

590

1.17

0.62

1.3

2.83

3.80

ug/l

0.93

547

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

443

1.20

0.61

2.2

2.5

0.86

0.87

nmol/l

0.05

379

(3032057) Clostridioides difficile [Presence] in Stool

1.67

0.61

2.0

1.9

—

(3012441) Differential panel - Pleural fluid

137

0.66

0.60

1.4

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

0.60

0.0

1.5

—

8.89

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.57

0.60

2.0

2.2

—

(3039000) Anion gap in Blood

362

1.22

0.60

4.5

8.3

11.33

11.29

mmol/l

0.03

325

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

105

1.43

0.60

1.5

1.7

—

1045939.09

iu/ml

—

(3044927) Protein electrophoresis panel - Urine

163

0.67

0.60

1.4

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

317

1.23

0.59

1.2

1.3

—

(3014891) Appearance of Pleural fluid

0.00

0.59

0.0

1.4

—

(3018572) Chloride [Moles/volume] in Blood

363

1.22

0.59

4.5

8.3

104.00

105.37

mmol/l

0.95

326

(3003338) MCHC [Mass/volume]

2155

21274

1.05

0.58

19.6

14.6

332.58

332.25

g/l

1.05

2138

21124

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

237

1.27

0.58

2.2

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

237

1.27

0.58

2.2

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.46

0.58

1.0

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

115

0.61

0.57

1.3

483.41

347.74

u/l

—

110

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

202

1.29

0.57

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

531

1.17

0.56

1.7

1.8

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.58

0.54

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

204

1.28

0.54

1.3

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.43

0.53

2.1

2.5

—

(3037121) Protein [Mass/volume] in Urine

684

0.86

0.52

2.2

3.3

0.16

0.30

g/l

1.60

276

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

101

1.39

0.49

1.3

1.5

10.00

13.15

u/l

0.82

(3036180) Methadone [Presence] in Urine

136

1.33

0.49

1.1

1.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

344

1.19

0.49

2.3

2.5

—

(3016879) Cocaine [Presence] in Urine

138

1262

1.10

0.48

2.0

2.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.52

0.48

1.0

1.2

—

(3017569) Oxygen content in Arterial blood

1.45

0.48

2.1

2.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

181

1.27

0.48

1.3

1.48

1.59

g/l

1.50

181

(40765089) Chromosome analysis panel - Blood by G-banded

102

1.37

0.47

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

114

1034

1.11

0.47

1.9

2.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

654

1.14

0.47

3.9

5.7

0.95

0.90

0.54

611

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

123

1121

1.10

0.46

1.5

—

(40768800) Prostate Pathology biopsy report

183

1.26

0.44

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.37

0.43

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

128

0.70

0.43

1.4

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

118

1079

1.10

0.43

2.2

2.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.61

0.43

1.0

—

(3019225) pH of Specimen

184

1971

0.93

0.43

3.9

3.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

122

1.31

0.42

1.0

1.1

—

(3042733) HLA Ab [Presence] in Serum

1.43

0.41

6.1

4.6

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

150

0.73

0.41

3.3

2.7

44154.55

39151.22

ug/l

0.67

150

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.41

0.0

1.1

—

21.64

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

132

1.29

0.40

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

110

1007

1.10

0.40

2.9

3.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

521

1.14

0.40

2.7

3.2

0.37

0.35

u/ml

0.22

281

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.37

0.40

1.7

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

171

0.76

0.39

2.2

3.4

27.34

37.24

mg/l

—

127

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.43

0.39

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.39

0.0

2.3

—

(3006270) Folate [Moles/volume] in Blood

187

1.23

0.39

1.1

367.00

402.59

nmol/l

0.34

174

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

160

1.25

0.38

1.4

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.35

0.38

1.8

2.1

—

(3006462) Nitrate [Presence] in Urine

107

1.31

0.37

2.4

2.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

189

1.22

0.36

1.4

1.5

1.38

1.28

promille

0.11

149

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

146

0.75

0.36

2.2

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

245

1.19

0.35

3.6

3.1

0.75

0.84

nmol/l

0.69

193

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.36

0.34

1.2

—

(3047189) Immunofixation for 24 hour Urine

1.34

0.34

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.32

0.33

1.7

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

560

5436

1.04

0.33

2.3

2.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

654

1.10

0.33

3.9

5.7

1.65

1.60

0.13

612

(3033705) Calcium.ionized [Moles/volume] in Venous blood

187

0.80

0.32

2.1

2.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

186

0.81

0.31

1.2

2.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.33

0.30

1.8

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.33

0.30

1.8

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

203

1.18

0.30

1.4

1.8

—

(3041806) Other cells [#/volume] in Blood by Manual count

157

1.21

0.29

2.3

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

194

1.19

0.29

3.4

2.4

1.37

1.36

g/24h

0.01

101

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

103

1.26

0.28

2.9

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

103

1.26

0.28

2.9

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

121

1137

1.07

0.27

1.5

1.7

3.31

4.27

mg/l

0.68

802

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

206

1.17

0.26

1.4

1.5

1.13

0.95

g/l

1.10

206

(3003434) Protein [Mass/volume] in Pleural fluid

171

0.82

0.26

1.4

31.81

33.15

g/l

0.16

154

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

111

1042

1.07

0.26

1.8

1.6

—

(3024471) HLA-A [Type]

0.68

0.26

1.0

—

(3024932) HLA-DR beta [Type]

0.68

0.26

1.0

1.1

—

(3035880) pH of Pleural fluid

0.67

0.25

1.0

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

636

1.09

0.25

3.4

3.5

37.52

2330.24

u/ml

0.84

548

(3010144) Erythrocytes [#/volume] in Synovial fluid

188

1.17

0.25

1.3

1.4

87187.94

64351.86

e6/l

0.10

133

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.27

0.24

3.3

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.27

0.24

3.3

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.27

0.24

3.3

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.73

0.24

1.8

2.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

161

1.18

0.24

2.8

2.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

233

0.86

0.23

1.6

2.1

13.65

25.67

mg/l

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(40758358) Immune stain study

0.00

0.21

0.0

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

173

1.16

0.21

1.5

—

(3003694) ABO and Rh group [Type] in Blood

758

7455

1.02

0.20

1.7

1.6

—

(4281824) Cell count and differential, peritoneal fluid

261

0.88

0.20

1.0

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

194

1868

1.04

0.20

3.4

4.0

85.17

37.78

ug/l

0.39

148

1446

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

156

1.15

0.18

1.4

2.2

2.11

2.08

u/field

—

(21494434) Karyotype in Bone marrow

153

0.85

0.18

1.3

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

887

0.95

0.17

1.5

—

(3022689) Creatine [Moles/volume] in Urine

0.76

0.17

1.0

1.8

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.75

0.17

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.13

0.15

3.3

2.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

317

0.91

0.15

1.3

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

171

0.88

0.14

9.2

3.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

117

0.85

0.13

2.4

1.5

0.94

1.35

nmol/l

—

(3015183) Erythrocyte sedimentation rate

169

0.89

0.12

1.7

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

171

1.11

0.12

1.9

2.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

1.16

0.11

1.0

1.1

—

184.29

—

(3039443) Prostate specific Ag panel - Serum or Plasma

221

1.09

0.11

1.9

1.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.11

0.09

1.6

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.09

0.09

1.0

—

(3048879) Bone marrow aspiration report

1.06

0.09

2.6

2.0

—

(4034850) Laboratory test

743

1.04

0.09

12.6

8.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1.13

0.09

3.7

2.3

45.18

50.57

umol/l

0.30

(1761482) Bacteria [#/volume] in Urine by Culture

451

0.95

0.08

3.9

3.8

—

(40765096) Chromosome analysis panel by Banding

1.07

0.08

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

113

0.88

0.08

2.8

3.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.09

0.08

1.4

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.86

0.07

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.08

0.07

2.1

2.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.03

0.07

2.1

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

213

0.94

0.06

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

179

0.95

0.03

1.5

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

449

1.02

0.03

3.5

3.6

125.28

27.90

u/ml

0.69

438

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

330

1.03

0.03

1.6

—

1644.44

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

104

1031

1.01

0.01

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

144

1.04

0.00

1.2

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

105

0.95

0.00

1.0

1.9

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

115

0.96

0.00

1.0

45.50

46.10

ng/l

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

145

1.03

0.00

1.5

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

141

0.99

0.00

1.3

238567.78

104882.65

e6/l

—

(3035933) Granulocytes/100 leukocytes in Blood

1.04

0.00

1.2

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

114

0.96

0.00

1.0

403.83

305.13

ng/l

—

(3022313) Gas panel - Capillary blood

802

1.00

0.00

3.1

3.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

113

0.97

0.00

1.0

972.33

732.92

ng/l

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

107

1.03

0.00

1.2

1.1

153.99

197.47

iu/ml

0.32

107

(3017704) Immunofixation for Urine

1.00

0.00

1.1

1.6

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.00

-0.00

1.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

116.00

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.3

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.3

—

7.50

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.01

-0.00

1.8

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.91

-0.00

1.0

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.01

-0.00

1.8

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.91

-0.00

1.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

14.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

2.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.9

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.00

-0.00

1.1

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

7.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.3

—

70.81

—

(3014271) Vancomycin [Susceptibility]

0.99

-0.00

2.3

2.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

4.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.00

-0.00

1.0

1.2

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.3

—

2.53

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

0.93

-0.00

1.2

1.4

32.60

60.14

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

-0.00

0.0

1.3

—

33.64

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.71

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.5

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

3.9

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_URTICA_DERTMATOG and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_URTICA_DERTMATOG	0.738 [0.63, 0.86]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.16

During the follow-up period (1.1.1998 — 31.12.2019), 366 out of 9810 females with L12_URTICA_DERTMATOG died.

Males

Parameter	HR [95% CI]	p-value
L12_URTICA_DERTMATOG	0.818 [0.71, 0.94]	0.006
Birth year	0.996 [0.99, 1.01]	0.415

During the follow-up period (1.1.1998 — 31.12.2019), 289 out of 3744 males with L12_URTICA_DERTMATOG died.

Mortality risk

Mortality risk for people of age

years, who have L12_URTICA_DERTMATOG.

N-year risk	Females	Males
1	0.082%	0.179%
5	0.449%	1.141%
10	1.149%	2.936%
15	2.057%	5.859%
20	3.711%	10.096%

Relationships between endpoints

↥

Index endpoint: L12_URTICA_DERTMATOG – Dermatographic urticaria

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dermatographic urticaria

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints